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GENERAL INTRODUCTION 
Mycobacteria are divided into 2 groups according to their rate of 
growth. Rapid growers, under optimal nutrition and temperature, 
produce, from dilute inocula, grossly visible colonies on solid media 
within 7 days. The slowly growing mycobacteria do not show growth 
until after that time (18). The rates of growth among the slowly 
growing mycobacteria vary considerably. Most of the data accumulated 
on slowly growing mycobacteria have been for the pathogens. 
Youmans and Youmans determined the generation time for 23 strains 
of Mycobacterium tuberculosis (51). Under optimal conditions, the 
generation time was 13 to 16 h. On less favorable media, the 
generation time was increased to 67 h. 
Ratledge reported similar generation times for M. tuberculosis, 17 
to 33 h, and a generation time of 43 h for Mycobacterium bovis (BCG) 
cultured in a fermenter (36). 
Mycobacterium leprae can be grown only vivo and has a genera­
tion time of 12 days (50). 
The two pathogens used in the research reported here also are 
slowly growing. Mycobacterium paratuberculosis has a generation time 
of 8 to 48 h depending upon culture conditions. The 8 h generation 
time was accomplished only within the last 2 years using a specified 
set of conditions. These conditions include culturing at 37°C in 
Middlebrook 7H9 liquid medium (7H9) supplemented with Dubos oleic-
albumin complex (DOAC) and ferric mycobactin P, at pH 5.9. The sta­
tionary culture should be no more than 3-mm deep (46). 
2 
Almost all of the testing of the susceptibility of mycobacteria to 
antimicrobial agents has been done using M. tuberculosis. These 
procedures are often unreliable and difficult to standardize. Reasons 
for this include the variation in stability of the drugs during 
storage, sterilization, media preparation, and the slow growth of the 
organisms. It is common procedure to incorporate antimicrobials into 
culture media as they are prepared. Such treatment may alter anti-
mycobacterial activity. Media and pH are important (17). Some 
components of the media, such as phospholipids and large molecular 
weight proteins in egg media bind active components of some 
antimicrobials (7, 42, 43). 
Unreliable results may occur during the prolonged incubation 
required of the M- tuberculosis test cultures. While growth may occur, 
it may be growth of a susceptible culture growing in the presence of a 
partially inactivated antimicrobial, and giving the false impression of 
a resistant culture (7, 44). This has been observed after 4 weeks 
incubation with cycloserine, ethambutol, and pyrazinamide (19), and 
after only a few days with other antimycobacterial agents (44). 
Rynearson and associates reported rifampin is inactivated in 
Middlebrook's 7H10 agar medium (7H10) after 2 weeks at 37°C (37). 
Subcultures of M. paratuberculosis require 12 weeks and subcultures of 
Mycobacterium avium require 6 to 8 weeks of incubation on egg yolk agar 
medium for colonies to be large enough to count (32). 
3 
M. paratuberculosis is refractory to most antimicrobials examined. 
This was shown in the limited research done on the organism in vitro 
(16, 35, 40). Although mycobacterial growth was inhibited by exposure 
to streptomycin sulfate. Smith concluded that it was improbable that it 
would have any practical application in the treatment of para­
tuberculosis, a disease of ruminants caused by M. paratuberculosis (35, 
40). Data collected by Eidus and Konst were from J^n vitro tests using 
a strain of M. paratuberculosis isolated 29 years earlier (16). 
Because this strain was no longer mycobactin dependent, the data are of 
limited value. 
McCarthy and Ashbaugh determined the generation time for M. avium 
using cells 1 ym in length. In their liquid medium B, which is a 
modification of 7H10, M. avium had a generation time of about 6 h (29). 
Mycobacterium avium is considered to be very resistant to anti­
microbials (10, 20, 25, 37, 48). Hobby and associates reported that M. 
avium showed little in vitro sensitivity in 7H10 to any of the anti-
tuberculous drugs, isonicotinic acid hydrazide (INH), ethionamide, 
streptomycin, cycloserine, viomycin sulfate, kanamycin sulfate, 
capreomycin sulfate, and sodium p^-aminosalicylate (20). David found 
from 43 to 64% of the M. avium strains he evaluated were resistant to 
INH, streptomycin, ethambutol, and rifampin (10). 
Kuze and associates investigated the effect of triple-drug regi­
mens on M. avium and found none active enough to recommend fully for 
clinical use. The most active combinations against M. avium were 
rifampin and kanamycin with either ethambutol or ethionamide (25). 
4 
Rynearson and associates found that M. avium was one of the three 
most resistant mycobacteria to rifampin. They evaluated 7 strains of 
M. avium along with 215 other strains of mycobacteria on 7H10 (37). 
However, Karlson found that minimum inhibitory concentrations (MIC) of 
rifampin against 6 strains of M. avium could be established in 3 
different media, an egg yolk medium, a serum medium, and 7H10 (22) . 
The MIC ranged from 0.5 to greater than lO-pg/ml. 
In an effort to develop a technique to obtain results more quickly 
and reliably than is possible on solid media by present techniques 
and to facilitate rapid screening for new antimicrobials, a number of 
14 investigators have worked developing procedures using C-labeled 
3 
metabolites or [ H]uracil (44). 
Initially, rapid radiometric procedures were used to detect the 
presence of microorganisms (28) or growth of microorganisms (4, 5, 9, 
14, 15, 26, 33). As early as 1956, Levin and associates measured 
14 14 14 
release of CO^ labeled with C from [ C]lactose and [ C]formate to 
detect coliforms in drinking water (28). In 1969, DeLand and Wagner 
detected produced by clinical pathogens utilizing [^^C]glucose 
(14). Since then, radiometric procedures have continued to be applied 
to clinical microbiology (12, 15, 27) including testing for suscep­
tibility to antimicrobials. 
Most of the susceptibility tests have measured the evolution of 
^^C-labeled CO^ from microorganisms incubated with ^^C-labeled sub­
strates (6, 8, 9, 11, 23, 33, 39, 45, 49). 
5 
Buddemeyer developed a technique to measure _in vitro metabolism 
14 
using C-labeled substrates. The growth system consisted of an inner 
sterile glass vial surrounded by a filter paper saturated with a 
concentrated toluene solution and moistened with 2N NaOH to absorb the 
14 CO^. This was placed inside another larger liquid scintillation 
counting vial. The test culture and radioactive substrate were placed 
14 in the inner vial. The CO^ generated was measured by an automatic 
liquid scintillation counter (4). 
Later, Yangco and associates adapted Buddenmeyer's technique to 
study susceptibility of M. avium to 8 antimycobacterial agents, INH, 
streptomycin, cycloserine, p-aminosalicyclic acid, ethambutol, 
rifampin, ethionamide, and clofazimine. When he compared the 
radiometric and conventional methods, the results from 61% of the tests 
were in agreement. Results were available in 72 h from the radiometric 
test in contrast to 21 days by the conventional method (49). 
In 1977, Middlebrook and associates, using a medium containing 
palmitic acid, detected growth of M. tuberculosis by measuring the 
14 
conversion of the substrate into CO^ in the Bactec Instrument, an 
automated ionization chamber (Johnston Laboratories, Cockeysville, MD) 
(33). This procedure has become known as the CO^ procedure when it is 
used to detect susceptibility of mycobacteria to antimicrobials. 
Siddiqi and associates compared Middlebrook's procedure using the 
Bactec instrument with the conventional agar dilution method on M. 
tuberculosis. There was 98% overall agreement. Eighty—seven percent 
6 
of the test results from the C-labeled substrate procedure were 
reportable within 4 days, 98% within 5 days (39). 
3 Other procedures utilize [ Hjuracil incorporation into the RNA of 
mycobacteria in the presence of antimicrobial agents to assess the 
effect on the viability of the organisms (3, 24, 31). 
Using the procedure developed by White and associates which 
14 3 
employed [ C]uracil, Benitez and associates used [ Hjuracil 
incorporation into the RNA of 4 mycobacteria, M. bovis (BCG) and M. 
bovis (BCG-R), an INH-resistant mutant, Mycobacterium kansasii, and 
Mycobacterium intracellulare, to measure cell viability in the presence 
of 4 antimycobacterial agents. They reported excellent correlation 
between the traditional susceptibility test requiring 1 to 4 weeks and 
the radioassay which required 4 to 48 h (3, 47). Arroyo and Medoff 
successfully treated a patient with an antimycobacterial agent selected 
on the basis of this susceptibility testing procedure (1). 
McDaniel and associates reported that the assay used by Benitez 
3 
and associates which used incorporation of [ Hjuracil by the RNA, was 
sensitive and reproducible for M. tuberculosis and yielded results in 
48 h (31). They incubated the organisms in a stationary culture at 
37°C in 5% CO^. They used the technique of White and associates to 
collect the incorporated isotope into a cold trichloracetic acid 
precipitate. The precipitated material was collected on glass fiber 
filters. Tubes were rinsed with 5% trichloracetic acid and O.IN HCl. 
Filters were placed in glass vials and counted in a Beckman liquid 
scintillation counter for 10 min (47). Results were available in 48 h. 
7 
Snider and associates at the Centers for Disease Control, coordi­
nated a comparison of this procedure and two methods using 
14 3 [ C]palmitic acid. They reported that the [ H]uracil technique 
provided poor agreement (64%) with existing techniques, was cumbersome, 
was difficult to teach, and was more time consuming to perform than the 
14 CO^ methods. At the same time, they suggested that researchers 
14 
continue refining and evaluating the CO^ methods (41). 
I had started my research before Snider's and associates' report 
was published. I had decided against the CO^ procedure because the 
collection of the CO^ seemed vulnerable to error, and without 
3 
appropriate monitoring, a safety hazard. The use of [ H]uracil seemed 
to be less complicated and less vulnerable to error. By the time 
Snider and associates reported their evaluation of the 2 rapid 
radiometric assays, I had accumulated data on a technique using 
3 [ Hjuracil incorporation. The procedure I had been developing was 
quite different from that Snider and associates reported, and the data 
gathered up to that time indicated it had potential to be a reliable 
technique. I decided to continue with the development of the procedure 
3 
using [ Hjuracil in spite of their publication. 
This dissertation is presented in an alternate format including 
prefacing information which includes preliminary investigations, and 2 
manuscripts to be submitted to the journal Antimicrobial Agents and 
Chemotherapy. The manuscripts have been prepared in the format of that 
journal. A summary and discussion follows the last manuscript. 
Literature cited throughout the dissertation is listed once following 
8 
the summary and discussion- There is a brief Appendix. These manu­
scripts represent original research developing a rapid radiometric 
assay to determine the susceptibility of M. avium and M. 
paratuberculosis to antimicrobial agents, the comparison of this assay 
to 2 other assay systems, and the modification and refinement of the 
assay to be able to determine the minimum inhibitory concentrations of 
the antimicrobials. 
9 
PRELIMINARY INVESTIGATIONS TO DETERMINE SOME PROCEDURES 
FOR THE RAPID RADIOMETRIC ASSAY 
10 
PROCEDURES AFFECTING THE CULTURING OF THE MYCOBACTERIA 
I investigated a number of procedures before completion of the 
development of the assay in order to conduct the assay under optimum 
conditions. These included procedures affecting the culturing of the 
mycobacteria, removal of the antimicrobial agents and nonincorporated 
3 [ Hjuracil from the test cultures, and measurement of the radioactivity 
in the liquid scintillation counter (Isc). While these preliminary 
investigations were important in the development of the assay, they 
would not be reported in a manuscript for publication. I am including 
these data in this section of the dissertation preceding the 
manuscripts. Each of these short experiments is discussed briefly to 
report what was done, the results, and how I chose to use those 
results. 
The Beckman LS-8000 Isc counted at 63% efficiency. Background 
counts in the instrument were 12 to 22 counts per minute (CPM) . 
The sources of the antimicrobials mentioned in these preliminary 
investigations are listed in Tables 1, 2, and 3 in Section I of this 
dissertation. 
Comparison of _2 incubation temperatures Mycobacterium avium 
cultures were incubated at either 37°C or 45°C on a gyratory shaker 
(150rpm) for 6 days to determine the optimum temperature for growth and 
multiplication. The microorganisms were cultured in Dubos broth at 
pH 7.4 with Tween 80 (0.5 ml/liter), enriched with Dubos oleic-albumin 
complex (DOAC) (lOO-ml/liter) Difco Laboratories, Detroit, MI) (32, 
3 Appendix A and B), and 0.5 pCi [ H]uracil/ml (New England Nuclear, 
11 
Boston, MA). Tween 80 is a sorbitan polyoxalkalene derivative and is 
used as an emulsifier. Incorporation at the 2 temperatures was compa­
rable until 24 h when the CPM from cultures at 45°C were 70% of those 
at 37°C. This persisted through 6 days. I chose to use 37°C for the 
remaining experiments, 
3 Comparison of liquid media for the incorporation of [ H]uracil 
I compared 4 liquid media in cultures shaken (150rpm) for periods of 4, 
6, 24, 48, and 96 h in the presence of 0.5 uCi tritium/ml. The media 
were Middlebrook 7H9 (7H9), 7H9 enriched with oleic acid-albumin— 
dextrose-catalase complex (OADC) (100-ml/liter), 7H9 enriched with 
albumin-dextrose-catalase (ADC) (100-ml/liter), and Dubos enriched with 
DOAC (100-ml/liter) (Appendix A and B). All were supplemented with 
0.5 ml Tween 80/liter. All media, enrichments and Tween 80 were from 
Difco Laboratories. I cultured Mycobacterium paratuberculosis on the 
same 4 media supplemented with ferric mycobactin P (2mg/liter), a 
growth factor derived from Mycobacterium phlei that is required by M-
paratuberculosis. M. avium was supported best on 7H9 with OADC at each 
of the incubation periods evaluated. The CPM increased from 21,000 at 
6 h to 43,000 CPM at 48 h, and to 52,000 CPM at 72 and 96 h. 
3 The greatest incorporation of [ H]uracil by M. paratuberculosis 
was in 7H9 with ADC and ferric mycobactin P. There were 10,000 CPM 
after 4 h of incubation, 73,000 CPM after 24 h, and 84,000 CPM after 
48 h. The M. paratuberculosis cultured in 7H9 with OADC and ferric 
mycobactin P yielded 12,000 CPM after 5 h incubation, 48,000 CPM after 
24 h, and 57,000 CPM after 48 h. 
12 
After 96 h incubation, there was a decrease in CPM on all cultures 
except M. avium in 7H9, and in 7H9 with ADC. These 2 media showed 
fewer CPM from the beginning of incubation, and continued to increase 
through 96 h of incubation. The washed, nontreated control cultures 
had 44 CPM. There were approximately 125,000 CPM available in each 
unwashed tube. 
I elected to use 7H9 enriched with GADC and ferric mycobactin P 
for both M. avium and M. paratuberculosis, so the same dilutions of the 
antimicrobials could be used. Whipple and Merkal reported that GADC 
was the preferred enrichment for stationary cultures of M. para­
tuberculosis incubated 7 days or longer in 7H9 broth at pH 6.6 (46). 
Effect of ethanol and dimethyl sulfoxide on the mycobacteria 
Some antimicrobials were insoluble in water, so I determined the 
effects on the mycobacteria of two potential solvents, dimethyl sulf­
oxide (DMSO) and ethanol. There was no reduction in incorporation of 
3 [ H]uracil by M. paratuberculosis in liquid medium containing DMSO at 
final concentrations of 3%, nor by M. avium at 5.4%. On 4 solid media, 
there was no reduction in the number of colonies of mycobacteria at 
50% DMSO. The 4 media were 7H10, egg yolk agar, serum agar, and Dubos 
with DOAC, Tween 80 and ferric mycobactin P (32) (Appendix B and C). 
Ethanol was used as a solvent for some antimicrobials insoluble in 
water, and to precipitate and kill the bacteria prior to processing for 
liquid scintillation counting. There was no decrease in incorporation 
3 
of [ H]uracil by the mycobacteria at concentrations of 10% ethanol or 
13 
lower. However, a final concentration of 50% ethanol prevented incor-
3 poration of [ H]uracil by M. avium and M. paratuberculosis. 
3 Evaluation of the effect of [ H]uracil on the mycobacteria by use 
of solid media I plated cultures of M. avium exposed to amikacin 
3 
sulfate and to amikacin plus [ H]uracil (0.5 uCi tritium/ml) on solid 
3 
media to determine the effect of [ H]uracil on the mycobacteria. After 
both cultures had been incubated 4 weeks at 37°C, the minimum 
inhibitory concentrations (MIC) of amikacin were the same (30 pg/ml), 
3 
showing that [ H]uracil did not affect the MIC of the organisms. 
14 
REMOVAL OF ANTIMICROBIAL AGENTS AND NONINCORPORATED [^H]URACIL 
During the preliminary investigations, I found not all of the 
antimicrobials were equally soluble, and the insoluble antimicrobials 
3 
seemed to trap the nonincorporated [ H]uracil. I investigated a number 
of techniques to determine the best method and the best solvent to 
3 
remove the excess antimicrobial and nonincorporated [ H]uracil from the 
assay system after incubation and before counting in the Isc. 
Techniques to remove the antimicrobial and nonincorporated 
3 [ H]uracil from the cultures Among the many techniques I evaluated 
3 to remove the excess antimicrobial and nonincorporated [ H]uracil were 
filtering, steaming, washing with gelatin, hot water, ethanol, or 
ethanol washes followed by cold or hot water washes. A summary of each 
procedure follows. 
Filtering There were a number of difficulties associated 
with filtering and washing the cultures of M. paratuberculosis and M. 
avium exposed to amikacin sulfate and to isonicotinic acid hydrazide 
(INH). 
I placed the cultures in disposable syringes fitted onto dispos­
able 13-mm 0.22 pm membrane filters (Millex, Millipore Corp., Bedford, 
MA) . I filtered out the mycobacteria by pushing the liquid portion 
through the disposable filters. The cultures were washed by pushing 
15-ml of 95°C water through the filters. But, when the mycobacteria 
were grown in the presence of large concentrations of an antimicrobial, 
it was physically difficult, and, in some cases, impossible to force 
15 
the fluid through the filter. Variable CPM resulted because the 
cultures could not be filtered nor washed sufficiently. Also, the 
filters did not solubilize in the tissue solubilizer, resulting in a 
heterogeneous counting system- This was undesirable because of self-
absorption by the filter. Also, a strong yellow color formed upon 
addition of the solubilizer, producing color quench. 
In addition, it was unsafe to work with the live cultures because 
the filters leaked occasionally. The mycobacteria were not killed 
before filtering because the methods of killing I examined caused 
clumps of precipitated material to form. Filtering the clumps, using 
the method in the preceding paragraph, was not possible. 
Steaming Cultures of M. avium and M. paratuberculosis 
treated with INH or amikacin were held for a fraction of a minute in 
flowing steam, and then washed with three 95°C water washes. This 
treatment did not improve solubility of the antimicrobials, and clumps 
developed in the vials containing more than 5-mg amikacin/ml. 
Frequently, the mycobacteria did not stay at the bottom of the tube and 
were lost during the decanting process. 
Gelatin wash I washed cultures of M. avium and M. 
paratuberculosis, which had been exposed to amikacin and INH, with 
5 gelatin concentrations ranging from 0.2 to 4%. At 4% concentration, 
the gelatin solidified; at 2%, it solidified during centrifugation; and 
at less than 1% it did not form a gelatin layer. CPM were variable and 
not reproducible. 
16 
Hot (95°C) water washes When I washed the cultures of M. 
paratuberculosis and M. avium with 3 hot water washes, the bacteria did 
not stay at the bottom of the minivial during decanting. This caused 
variability of CPM and prevented reproducible data. 
Ethanol washes Early in my preliminary work, I washed 
cultures of mycobacteria, which had been grown in the presence of 
selected antimicrobials, 3 times with 95% ethanol in a refrigerated 
centrifuge. When I plotted the CPM against time, the response curves 
were one of two shapes, those of susceptible mycobacteria, or those of 
resistant mycobacteria. 
However, when I evaluated some other antimicrobials, there seemed 
to be 2 other types of responses. These responses were not anticipated 
because in earlier experiments using solid media, these antimicrobials 
had been inhibitory for either or both M. paratuberculosis or M. avium. 
One of these responses showed inhibition of the incorporation of 
3 [ H]uracil by the mycobacteria equally well at all concentrations of 
the antimicrobial. That is, the mycobacteria seemed to be equally 
susceptible to all concentrations of the antimicrobial. 
With the other response, there were more CPM from the control 
cultures without antimicrobials and from the 2 most concentrated 
amounts of the antimicrobials than from the 4 least concentrated 
amounts of the antimicrobials. Therefore, it gave the appearance that 
the 2 most concentrated amounts of the antimicrobial stimulated 
3 incorporation of [ H]uracil. 
17 
When I conducted the assay using 5 concentrations of the anti­
microbial, but without mycobacteria, the curve was proportional to the 
concentration of amikacin. At that time it became clear that the 
3 
nonincorporated [ H]uracil had not been washed away. Large amounts of 
the antimicrobial had been retained, trapping the nonincorporated 
[^H]uracil. 
One ethanol wash followed by room temperature (22°C) or hot 
(95°C) water washes Most of the antimicrobials were soluble in 
water, so I tried a room temperature water wash after the ethanol 
washes. While that decreased the CPM somewhat, the shape of the 
3 
response curve remained the same. More [ H]uracil was removed each 
time I added another water wash. 
Because solubility usually increases with increased temperature, I 
heated the wash water to 95°C, and centrifuged the samples in the 
absence of refrigeration. I evaluated a series of 1 through 4 hot 
water washes after the ethanol precipitation. Not all the excess 
antimicrobial was removed with 1 wash. The range of CPM was somewhat 
smaller from the assay tubes washed 3 times than from those washed 
twice. There was no difference in CPM between 3 and 4 washes. I 
3 decided the optimum washing procedure to remove the excess [ H]uracil, 
and antimicrobial was 1 ethanol wash followed by 3 hot water washes. 
Using that procedure, it was possible to establish susceptibility and 
resistance response curves of the mycobacteria to all antimicrobials 
evaluated. 
18 
PROCEDURES AFFECTING MEASUREMENT OF RADIOACTIVITY 
Good techniques used when culturing the mycobacteria could have 
been negated by poor techniques used in preparation of the samples for 
counting in the Isc. The following parameters were investigated to 
achieve a reliable procedure for preparation of the samples for 
counting and the counting process. 
Rehydration of bacteria Dehydrated bacteria cannot be com­
pletely solubilized. I rehydrated the mycobacterial cells dried at 
72°C to optimize solubilization with the solubilizer. The rehydration 
capacities of Tween 80 (0.5%) and water were compared. Rehydration was 
accomplished faster and more completely by Tween 80 than by water. 
Solubilization of bacteria Bacterial cells require solubili­
zation to achieve a homogeneous system for reproducible measurement of 
radioactivity. Some cultures of M. avium, which had been exposed to 
amikacin, were held in the tissue solubilizer for 16 h at room 
temperature (22°C), others for 3 h at 54°C. 
CPM were measured immediately, and after 2, 4, and 24 h in the 
liquid scintillation counting cocktail. When I measured the CPM of the 
samples immediately after solubilization, there were more CPM from the 
most concentrated levels of the antimicrobials than there were at the 
same concentrations when the samples were counted after 2, 4, and 24 h 
in the liquid scintillation counting cocktail. At the greater dilu­
tions of the antimicrobial, the CPM did not change at the various 
counting times. 
19 
The results from the tissue solubilization at the two temperatures 
were equivalent. I chose to solubilize the mycobacteria at 54°C for 3 
h in the rapid radiometric assay. 
Extent of chemiluminescence Solubilizers, which are strong 
organic bases, should solubilize the bacteria but cause minimum quench­
ing. However, chemiluminescence is a common problem when using 
solubilizers. I performed experiments without radiochemicals to 
determine the extent of chemiluminescence caused by the solubilizer. 
Wet bacteria presented with Soluene-350 (Packard Instrument Co., 
Inc., Downers Grove, IL) a commercial solubilizer, can be solubilized 
after 3 h at 54°C, or after 16 h at room temperature; however, 
chemiluminescence usually is resolved more quickly when solubilization 
takes place at higher temperatures. 
Samples were prepared in the normal manner, but without 
3 [ H]uracil. They were counted at 6 time-intervals between 1 min and 
2 h after preparation. I included a commercially available reference 
background sample. There were more CPM recorded during each of 4 
counting sessions from zero-time to 1 h following preparation than when 
the CPM were measured again 2 h after preparation. Two hours after 
preparation the samples were at or near background CPM. There was no 
difference between the CPM from the cultures solubilized at 54°C and 
those solubilized at room temperature. I concluded that chemi­
luminescence can be controlled by delaying counting the samples until 
2 h after preparation. The temperature at which the samples were 
solubilized did not influence the CPM. 
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Determination of the level of background radioactivity within the 
radioassay system To determine the level of background 
radioactivity within the radioassay system, I processed M. 
3 paratuberculosis without [ H]uracil. The mycobacterial cells were 
solubilized 3 h at 54°C. I counted the samples 6 times within 4 h, and 
then again at 24 h. When I counted them at 24 h, the CPM were equiva­
lent to those for the background of the Isc (12 to 22 CPM). The CPM at 
other counting times were within 10 CPM of the background. A variation 
of 10 CPM is acceptable. 
Extent of fluorescence Natural fluorescence can occur and 
interfere with the accurate measurement of the CPM from samples pre­
pared and counted in the light. I measured the CPM from processed 
cultures immediately after the addition of counting cocktail, after 4 h 
and 72 h in the dark, and again after agitating them in the presence of 
light. Fluorescence was absent at all times. 
Optimum amount of liquid scintillation counting cocktail 
I evaluated various amounts of counting cocktail to determine the 
volume required to recover the greatest number of CPM in the minivials. 
Volumes from 1 to 7-ml were evaluated at 1 ml intervals. The most CPM 
were recorded when 5-ml of counting cocktail was used. The least 
number of CPM were recorded with 1 ml. I chose to use 5-ml counting 
cocktail in the assay. 
Reproducible CPM at several time-intervals following addition of 
counting cocktail I measured the CPM in samples at various times 
after the addition of the counting cocktail to determine the amount of 
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standing time needed to achieve reproducible counts. Low-count samples 
such as those from a mycobacterial culture susceptible to an 
antimicrobial were reproducible after 30 min. High-count samples, such 
as those from nontreated controls, were reproducible within 5 min. 
Comparison of time-intervals between adding the liquid scintil­
lation counting cocktail and counting the samples The length of 
time between the addition of counting cocktail to the samples and the 
counting procedure, can influence the number of CPM measured. To 
determine the optimum time—interval, I measured samples of M. avium 
immediately after adding the counting cocktail, after standing 4-1/2 h, 
and again after 27 h. I found the CPM for the mycobacteria at each of 
the 7 concentrations of antimicrobial were similar at each of the 3 
time-intervals. 
When the procedure was repeated in the absence of bacteria, the 
CPM from the tubes with the most concentrated level of the anti­
microbial were 10 times higher when the samples were measured immedi­
ately than after standing 27 h. At the 1:3 dilution of the anti­
microbial, the CPM were 2 times higher when the counting was done 
immediately than after standing 27 h. The CPM after standing 4-1/2 h 
were similar to those after 27 h. Length of time did not make a 
difference at the 1:25 and greater dilutions of the antimicrobial. 
Because there was little difference between the 4-1/2 and 27 h 
standing time for samples without mycobacteria, I evaluated a standing 
time less than 4-1/2 h. I counted samples with 6 dilutions of anti­
microbial in the absence and presence of M. avium at 2 and 18 h after 
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exposure to the cocktail. The CPM after 2 and 18 h standing times were 
equal at the same concentration of the antimicrobial. Therefore, I 
allowed a 2 h standing period after the addition of the counting 
cocktail before measuring the CPM in the Isc. 
After the above procedures were established, I proceeded with the 
development of the radioassay. 
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SECTION I. DEVELOPMENT AND COMPARISON OF A RAPID RADIOMETRIC ASSAY 
WITH TWO OTHER METHODS TO DETERMINE THE SUSCEPTIBILITY OF 
MYCOBACTERIUM PARATUBERCULOSIS AND MYCOBACTERIUM AVIUM 
VITRO TO ANTIMICROBIAL AGENTS 
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ABSTRACT 
I compared three assay systems to determine the antimicrobial 
susceptibility of Mycobacterium paratuberculosis and Mycobacterium 
avium. They were an agar dilution assay, an optical density measure­
ment assay, and a rapid radiometric assay. The rapid radiometric assay 
3 I developed used the inhibition of incorporation of [ H]uracil into the 
mycobacterial RNA in the presence of antimicrobial agents to measure 
the susceptibility of the mycobacteria to antimicrobials. Twenty-seven 
antimicrobials were evaluated using the three assay systems. 
Long incubation periods of 12 to 16 weeks were a disadvantage in 
the agar dilution assay. Many of the antimicrobials evaluated are 
known to retain only partial activity or become inactive after several 
days to 4 weeks at 37°C. 
The optical density assay was unsatisfactory because the anti­
microbials frequently produced cloudy suspensions or dark—colored 
solutions which could not be measured accurately in a spectrometer. 
There was 83.3% agreement between the agar dilution and rapid 
radiometric assays of the susceptibility of M. avium and 69.2% agree­
ment for M- paratuberculosis. The rapid radiometric assay was com­
pleted in 3.5 days and circumvented problems associated with the two 
other assays. The technique did not determine minimum inhibitory 
concentrations. 
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INTRODUCTION 
The standard ^  vitro methods for determination of susceptibility 
of Mycobacterium tuberculosis to antimycobacterial agents require at 
least 3 to 4 weeks to complete because of the slow growth of M. 
tuberculosis (44). These incubation times are longer when dealing with 
mycobacteria that grow more slowly such as Mycobacterium avium and, 
especially, Mycobacterium paratuberculosis (32). The standard agar 
dilution assay requires 6 to 8 weeks for M. avium and 12 weeks for M. 
paratuberculosis. 
Some compounds lose efficacy during prolonged incubation. Vestal 
reported that some antimycobacterial agents are no longer active in the 
medium after several days of incubation (44). Rynearson and associates 
reported that rifampin is inactivated in Middlebrook's 7H10 agar medium 
(7H10) after 2 weeks at 37°C (37). Hawkins reported that 3 other 
antimycobacterial agents are partially inactivated after 4 weeks of 
incubation (19). A more rapid assay would circumvent some of these 
difficulties caused by long incubation times. 
During the last decade, a number of rapid radiometric assays have 
been developed to detect the presence and/or growth of microorganisms, 
or determine susceptibility to antimicrobials. The most common 
procedure has been to determine the susceptibility of microorganisms by 
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measuring the evolution of CO^ from microorganisms exposed to 
^^C-labeled substrates (3, 4, 5, 6, 8, 9, 11, 12, 13, 14, 15, 23, 27, 
28, 33, 45). This procedure has become known as the CO^ procedure. 
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Another rapid radiometric assay was developed to determine suscep­
tibility of microorganisms to antimicrobial agents by measuring the 
3 incorporation of [ Hjuracil into the RNA of microorganisms. This assay 
used the procedures of precipitating microorganisms, cultured in the 
3 presence of [ Hjuracil, with cold trichloracetic acid, and then 
filtering the microorganisms onto a glass fiber filter (3, 24, 31, 45). 
The filter with the microorganisms was placed in a liquid scintillation 
counting vial, and the 6-emissions from the tritium were detected and 
recorded in a liquid scintillation counter (Isc). 
I developed a rapid radiometric assay (RRA) for determining the 
susceptibility of M. avium and M. paratuberculosis to antimicrobials. 
This technique depended on the differences in incorporation of 
3 [ Hjuracil by mycobacteria in the presence and absence of anti­
microbials. The objective of this study was to compare this RRA with 2 
more conventional methods to determine susceptibility of microorganisms 
to antimicrobials, and to determine if the RRA would be an equivalent 
or better technique for determining the susceptibility of M. avium and 
M. paratuberculosis in vitro to antimicrobials. 
The two more conventional methods used to determine susceptibility 
of microorganisms to antimicrobials are the turbidimetric and agar 
dilution assays. The effect of antimicrobials on growth and multipli­
cation of microorganisms in liquid medium can be measured by changes in 
turbidity (24, 34). Although the susceptibility of M. tuberculosis has 
been determined by changes in turbidity, the method is not readily 
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applicable to all mycobacteria, because of their slow growth and 
tendency to clump in liquid medium (24). Clumping of M. para-
tuberculosis is reduced in the presence of wetting agents but not 
eliminated. The technique I used to measure changes in turbidity as a 
result of the effect of antimicrobials on M. avium and M. para-
tuberculosis is referred to as the optical density assay (ODA). 
The second method, the agar dilution assay, evaluates suscep­
tibility of the microorganisms by diluting the antimicrobial in an agar 
medium, and counting colonies on treated vs. nontreated solid media. 
The agar dilution assay recommended by the U.S. Department of Health 
and Human Services, Public Health Service, Centers for Disease Control 
(CDC) to determine the susceptibility of M. tuberculosis to 
antimicrobials uses dilutions of antimicrobials incorporated into the 
agar medium during preparation of the medium (44). I developed an agar 
dilution procedure for use with M. avium and M. paratuberculosis, which 
I have referred to as the colony forming units assay (CFA). 
There are no antimicrobials known to cure infections in animals 
caused by M. paratuberculosis or M. avium nor infections in humans by 
M. avium. Most often, human patients with infections caused by M. 
avium are treated with a multiple drug regimen of antimycobacterial 
agents. 
I chose the antimicrobials used in this research for a number of 
reasons. Some were antimycobacterials used in the treatment of tuber­
culosis caused by mycobacteria other than M. paratuberculosis or M. 
avium. Others had been investigated by researchers and had shown some 
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inhibition of mycobacteria, some are broad spectrum antibiotics, and 
some are used in the treatment of other infectious diseases. I 
included penicillin because in some of my earlier work, penicillin had 
shown some promise of effectiveness during vivo experiments with 
gerbils experimentally infected with M. paratuberculosis. Most of the 
antimicrobials I used are licensed for use in the treatment of humans; 
a few were veterinary products. 
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MATERIALS AND METHODS 
Cultivation of mycobacteria for storage All handling 
procedures involved in isolating, culturing, harvesting, and preparing, 
the mycobacteria for storage were carried out in a biological safety 
cabinet. Centrifugation was done in centrifuge safety cups with 
sealable tops (International Equipment, Needham, MA). 
M. avium, NADC 33, was isolated from a swine on Merkal's egg yolk 
agar (egg yolk agar) and subcultures were grown on the same medium in 
Roux bottles (32) (Appendix C). Mature cultures were harvested, using 
sterile techniques. About 25-ml sterile water were flooded onto each 
bottle and allowed to stand 30 min to help loosen the organisms. A 
sterile glass rod was used to scrape loose the organisms from the sur­
face. The suspension was aspirated into a sterile 25-ml pipette, then 
transferred into several sterile 50 ml centrifuge tubes, and centri-
fuged 30 min at 890 x g in a refrigerated centrifuge (International 
portable centrifuge, model PR-2), The supernatant was discarded and 
the mycobacteria were suspended in sterile water and the centrifugation 
process was repeated. The second supernatant was discarded. These 2 
centrifugation procedures removed the larger pieces of agar which 
adhered to the mycobacteria when they were harvested. Then, the 
mycobacteria, suspended in water in sterile 50-ml ultracentrifuge 
tubes, were centrifuged 30 min at 45,000 x g in a Beckman Model L 
ultracentrifuge. This centrifugation procedure washed and packed the 
mycobacteria in the bottom of the centrifuge tube. The organisms were 
suspended in Dubos liquid culture broth (Dubos) enriched with Dubos 
30 
oleic-albumin complex (DOAC) (100 ml/liter), and Tween 80 
(0.5 ml/liter) (Difco Laboratories, Detroit, MI) (32, Appendix A 
and B). Tween 80 is a sorbitan polyoxalkalene derivative and is used 
as an emulsifer. One—ml aliquots containing 1 X 10^^ CFU/ml were 
stored at -70°C. 
M. paratuberculosis, NADC 21, was isolated from the terminal ileum 
of a sheep. The mycobacteria were isolated on egg yolk agar containing 
ferric mycobactin P (2mg/liter), a growth factor isolated from 
Mycobacterium phlei (32) (Appendix C). Subcultures were grown, 
harvested, and stored using the same procedures I used for M. avium. 
Mycobacterium paratuberculosis was stored in aliquots containing 1.2 X 
10^ CFU/ml. 
Preparation of working suspensions of mycobacteria I used the 
following procedure to prepare bacterial suspensions for the 3 assay 
techniques. I diluted the thawed aliquots of M. paratuberculosis and 
M. avium in Middlebrook's 7H9 culture broth (7H9) enriched with oleic 
acid-albumin-dextrose—catalase complex (GADC) (100 ml/liter) and 
Tween 80 (0.5 ml/liter) (Difco Laboratories) in 300-ml nephelo culture 
flasks (Appendix B). Medium for culturing M. paratuberculosis 
contained ferric mycobactin P (2 mg/liter). 
3 Radiochemical The 7H9 broth was pulsed with 5-[ H]uracil in 
sterile water (specific activity >25 Ci/mmol) (New England Nuclear, 
Boston, MA) to a final concentration of 4 uCi/ml. Nonlabeled uracil 
was not added to the broth. I divided the volume of broth, using some 
for nontreated controls and the remainder for the test cultures. 
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Antimicrobial agents I filter-sterilized antimicrobials 
diluted in water or dimethylsulfoxide (DMSO) through disposable mem­
brane filters (0.22 jam) (Millex, Millipore Corp., Bedford, MA), I 
added the antimicrobial to be tested to one of the flasks at zero time 
and to another after 24 h of incubation. The flasks were incubated on 
a gyratory shaker (150 rpm) at 37°C for up to 23 days. 
The antimicrobials, the concentrations used, and their sources are 
listed in Tables 1, 2, and 3. I determined the susceptibility of M. 
avium and M. paratuberculosis to 27 antimicrobials at zero time. I 
determined the susceptibility of M. avium to 9 antimicrobials added to 
the cultures after 24 h incubation. 
Procedures for the 2 assays All procedures except centrifuging 
and drying the cells were carried out in a biological safety cabinet. 
There were 8 flasks for each antimicrobial tested, 4 for each of the 
2 mycobacteria. There were 2 flasks with antimicrobials and 2 without 
for each mycobacterium. The tritium was in one flask with anti­
microbials and in one flask without; there was no tritium in the other 
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set of flasks. The flasks containing the tritium had 1 X 10 colony 
forming units (CPU) M. avium/ml and 1.2 X 10^ CPU M. 
paratuberculosis/ml. These flasks were used for the RRA and CFA. The 
4 flasks without the tritium contained 1 X 10 CFU M. avium/ml and 1.2 X 
10^ CFU M. paratuberculosis/ml and were used in the ODA. The cultures 
to be measured in the spectrometer for the ODA required a larger number 
of CFU/ml than the cultures for the RRA and CFA. A larger number of 
CFU/ml was required to be detected optically, and to be able to detect 
TABLE 1. Comparison of 3 assay systems for measuring susceptibility of M. avium in vitro 
Antimicrobial agent Assays 
Name Concn. 
(quantity/ml) 
Source^ 
RRA 
Percentage 
incorporation 
after 3 days 
(%) 
ODA 
1 log ( 
difference 
(days) 
CFA 
2 log j 
difference 
(days of 
treatment) 
Amikacin sulfate 6.3 mg 2 5 6 1 
£-Amlnosalicyclic acid 65.2 ug 11 2 NA^ 2 
(PAS), pH 7.4 f 
Bacitracin 9.6 yg 11 32 NA NA 
9.6 pg 11 4 NA NA 
4 mg 11 2 ND® 3 
Capreomycln sulfate 14.8 mg \ 1 4 1 Cefazolin sodium 50 ijg 3. 6 5 3 
Cephalexin 50 wg 4 6 2 
Cephaloglycin 50 vig 3 17 6 3 
Cephaloridine 50 wg 3 ND 2 
Cephalothin sodium 50 pg 6 6 3 
Cephapirin sodium 50 iJg 2|, 2 3 2 
Cephradine hydrate 47.3 jjg 3" 19 3 
Chloramphenicol 2.5 mg 11 2 ND 3 
Chlortetracycllne HCl 12.5 Jig 1 1 NA 2 
2.5 mg 8 ND. 
ND-] 
2 
Doxycycline hyclate 25 wg I" 1 2 lithambutol HCl 3 yg 4 2 3 
Isonicotinic acid 130 pg 11 2 6 2 
hydrazide (INH) If 
Laurie acid 200 Mg 11 ND 7 2 
Lauricidin 0.034 ug 5 10 ND 2 
Lauricidin plus F 100 yg 5 50 NA 3 
Lauricidin plus III 100 Mg 5 25 NA 3 
Minocycline HCl 10 pg 11 2 ND 2 
Oxytetracycline HCl 5 mg 11 4 ND 2 
Penicillin G potassium 1.4 XIO 
units 
9 2 4 1 
Pyrazinamide, pH 7.4 100 wg 11 100 NA NA 
1 mg 11 100 NA. 
ND^ 
NA 
Rifampin 1.5 mg 11 1 1 
Streptomycin sulfate 36.6 yg 3 4 6 2 
Viomycin sulfate 10 mg 9 2 4 1 
^Numbers refer to sources in Table 3. 
'^Percentage of CPM in treated cultures compared to 100% CPM in nontreated cultures after 3 
days incubation. 
^Days incubation required to detect 1 log difference between absorbance readings of 
nontreated and treated cultures. 
'^Days of treatment in nephelo culture flask before detection of 2 log difference in CPU 
between nontreated and treated cultures. All of these treatments were followed by 6 to 8 weeks 
incubation before this difference was detected. 
^One log difference between absorbance readings of nontreated and treated cultures not 
achieved. 
^Two logs difference in CPU between nontreated and treated cultures not achieved. 
^Not done. 
'^Gift from source listed. 
^Not done, cloudy suspension. 
•^Not done, dark color. 
'Slot sampled on day 3. 
Table 2. Comparison of 3 assay systems for measuring susceptibility of M. paratuberculosls 
in vitro 
Antimicrobial agent Assays 
RRA ODA CFA 
Percentage 2 log 
a 
Incorporating 1 log ^ difference 
Name Cone. Source after 3 days difference (days of 
(quantity/ml) (%) (days) treatment) 
Amikacin sulfate 6.3 mg 2 3 10^ 1 
£-Arainosalicyclic acid 65 Mg 11 Contaminated NA 13 
(PAS), pH 7.4 
Bacitracin 9.6 wg 11 17 NA NA 
Capreomycin sulfate 14.7 mg 3 
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14 NA NA 
Cefazolin sodium 50 Mg 30 NA NA 
Cefoxitin sodium 50 lig 8 100 NA NA 
Cephalexin 50 iJg 3g 100 NA NA 
Cephaloglycin 50 pg 3 100 NA NA 
Cephaloridine 50 pg 3 39 11 3 
Cephalothin sodium 50 Mg 3 100 NA NA 
Cephapirln sodium 50 pg 2 
3^ 
20 NA 11 
Cephradine hydrate 50 pg 30 NA 3 
Chloramphenicol 2.5 mg 11 3 NA NA 
Chlortetracycline HCl 5 mg 1 3 ndJ- 1 
D-cycloserine 20 mg 11 4 ND 6 
Ethambutol HCl 3 pg 7 a® 100 NA NA 
Isonicotinic acid 30 pg 11 6 13 5 
hydrazide (INH) 
Laurie acid 200 pg 11 1 10 1 
Lauricidin 100 pg 5 39 10 NA 
Lauricidin plus F 100 pg 5 56 NA NA 
Lauricidin plus III 100 ug 5 100 NA NA 
Minocycline HCl 10 jjg 11 29 NA. 
ND^ 
2 
Oxytetracycline 5 mg 11 2 1 
injectable A 
Penicillin G potassium 1.4X10^ 
units 
9 6 NA NA 
Pyrazinamide, pH 7.4 1 mg 11 100 NA NA 
Rifampin 1.5 mg 11 2 ND 1 
Streptomycin sulfate 36.6 )jg 3 7 10 4 
^Numbers refer to sources in Table 3. 
^Percentage of CPM in treated cultures compared to 100% CPM in nontreated cultures after 
3 days incubation. 
'^Days incubation required to detect 1 log difference between absorbance readings of 
nontreated and treated cultures. 
^Days of treatment in nephelo culture flask before detection of 2 log difference in CPU 
between nontreated and treated cultures. All of these treatments were followed by 12 weeks 
incubation before this difference was detected. 
0 One log difference between absorbance readings of nontreated and treated cultures not 
achieved. 
^Two logs difference in CPU between nontreated and treated cultures not achieved. 
®Gift from source listed. 
^Not done, cloudy suspension. 
^Not done, dark color. 
Table 3. List of sources for antimicrobial agents 
Reference Source 
1 American Cyanamid 
Princeton, NJ 
2 Bristol Laboratories 
Syracuse, NY 
3 Eli Lilly & Co., 
Indianapolis, IN 
Farmitalia Carlo Erba 
Milan, Italy 
Jon J. Kabara, Ph.D. 
College of Osteopathic Medicine 
Michigan State University 
East Lansing, MI 
6 Kowa Co., Ltd. 
Nagoya, Japan 
7a Lederle Laboratories Division 
American Cyanamid 
Pearl River, NY 
7b Lederle Laboratories 
Wayne, NJ 
8 Merck, Sharp and Dohme 
West Point, PA 
9 Pfizer Laboratories Division 
Pfizer, Inc. 
New York, NY 
10 Schering Corporation 
Kenilworth, NJ 
11 Sigma Chemical Co. 
St. Louis, MO 
12 Squibb Institute for 
Medical Research 
Princeton, NJ 
13 Ives Laboratories, Inc. 
685 Third Avenue 
New York, NY 
14 Wyeth Laboratories, Inc. 
Philadelphia, PA 
^Source of antimicrobials identified by this number in 
Tables 1 and 2, 
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a change in the optical density within a reasonable length of time. 
When this larger number of CFU/ml was used in the RRA. and CFA, 
3 incorporation of the [ H]uracil by the mycobacteria reached a plateau 
sooner than was desirable, and no determination of their susceptibility 
or resistance to antimicrobials could be determined. 
Rapid radiometric assay I removed four 500-iil aliquots from 
treated and nontreated nephelo culture flasks at zero time and then at 
24-hour intervals for 4 to 10 days. The aliquots were placed in four 
8-ml minivials (Research Products International, Elk Grove Village, IL) 
for use in a Isc. Cells in each minivial were precipitated with 7-ml 
95% ethanol, and were centrifuged 20 min at 890 x g. The ethanol 
precipitated cells were rinsed with a series of three 5-ml hot water 
washes (95°C), and then were dried at 54°C for 10 to 12 h. The cells 
were rehydrated with 50-pl 0.5% Tween 80 for 20 to 30 min, and then 
were solubilized with 0-5 ml Soluene-350 (Packard, Downers Grove, IL) 
in tightly capped vials at 54°C for 4 h. This procedure allowed for a 
homogeneous counting system. When the vials cooled to room tempera­
ture, a 5-ml volume of Liquifluor (New England Nuclear) scintillation 
counting cocktail was added to each assay tube. After the tubes were 
allowed to stand 2 h at room temperature to control chemiluminescence, 
the radioactivity was measured for 2-min in a Beckman LS—8000 Isc 
(Beckman Instruments, Inc., Irvine, CA). The background activity 
measured approximately 15 to 20 counts per min (CPM). There were at 
least 30,000 CPM available to the mycobacteria in each minivial. 
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Optical density assay I measured the optical density of the 
cultures in the nephelo culture flasks as absorbance in a Bausch & Lomb 
Spectronic 20 spectrometer at 540 nm. The machine was calibrated with 
a 1:1 solution of water and 7H9 culture broth with OADC and monitored 
closely throughout the period of measuring. Optical density of the 
cultures was determined daily, for 4 to 9 days. No readings below 0.01 
absorbance were recorded. There was no reading greater than 0.19 
absorbance for M. paratuberculosis nor 0.375 absorbance for M. avium. 
An antimicrobial was considered inhibitory when the absorbance reading 
of the treated culture was 1 log lower than the absorbance reading of 
the nontreated culture. M. paratuberculosis cultures containing 
1 X 10^'^ CFU showed an absorbance of 0.01. There is an increase of 1 
log of organisms from an absorbance reading of 0.03 to 0.086. A 
difference of 1 log in the absorbance reading is equivalent to nearly 2 
logs of microorganisms (46). 
Colony forming units assay At zero time, and thereafter, daily 
for 5 to 6 days, I plated 0.25 ml from each of four 10—fold dilutions 
of the mycobacterial cultures from the nephelo culture flasks onto egg 
2 yolk agar in disposable 25 cm tissue culture flasks. The medium used 
for cultivation of M. paratuberculosis contained ferric mycobactin P. 
When volumes larger than 0.25 ml were plated onto the disposable tissue 
flasks, the surface of the medium remained too wet to allow growth of 
isolated colonies-
The cultures of M. avium were incubated at 37°C for 6 weeks before 
the colonies were counted. The cultures of M. paratuberculosis were 
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incubated at 37°C for 12 weeks before the colonies were counted. An 
antimicrobial was evaluated as effective when there were 2 logs fewer 
CFU on the treated culture than on the nontreated culture. This 
criterion for evaluation is an adaptation of the procedure recommended 
at the CDC for use with the agar dilution assay used for susceptibility 
testing of M. tuberculosis (44). 
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RESULTS 
3 DMSO at 3% did not reduce incorporation of [ Hjuracil by myco­
bacteria in the liquid culture system. At 50%, DMSO was tolerated by 
both mycobacteria on solid medium. 
There was a linear relationship between the incorporation of 
3 [ Hjuracil by M. avium, measured in CPM, and the numbers of colonies of 
M. avium recovered from cultures incubated from zero time throughout 
3 
the incubation period. Because the incorporation of the [ Hjuracil was 
directly proportional to the increase in numbers of colonies recovered, 
3 incorporation of [ Hjuracil was a measure of the growth of the 
mycobacteria. Therefore, the measurement of the incorporation of 
3 [ Hjuracil was a valid assay of the effect of antimicrobials on the 
mycobacteria. 
The same linear relationship was observed for M. paratuberculosis 
from 3 days through the remainder of the incubation period. 
When the CPM from the numerous RRAs were plotted against time, 
there was no difference in the CPM between the treated and nontreated 
cultures before 3 days of incubation. Therefore, the percentages of 
incorporation shown in Tables 1 and 2 were computed from data collected 
3 days after the cultures were established. Percentages were computed 
by dividing the CPM from the treated cultures by the CPM from the 
nontreated cultures, and then multiplying by 100. A high percentage 
number indicated that nontreated and treated cultures incorporated 
3 
similar amounts of [ Hjuracil; low percentages indicated greater 
3 differences of incorporation of [ Hjuracil between nontreated and 
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treated cultures. The data I collected led me to conclude that the 
mycobacteria were susceptible when there were 10% or fewer CPM in the 
treated cultures than in the nontreated cultures. 
The results of the 3 assays to determine the susceptibility of M. 
avium to the antimicrobials are shown in Table 1. 
Rapid radiometric assay for M. avium After 3 days incubation 
with M. avium, 77%, or 23 of the 30 assays of antimicrobials tested, 
3 
reduced the incorporation of [ H]uracil by M. avium to 10% or less of 
the incorporation of the untreated control cultures of M. avium. In 
23% of the RRAs, M. avium incorporated 17 to 100% of the amount of 
3 [ H]uracil incorporated in nontreated controls. 
I found there was no advantage to wait until M. avium cultures had 
been incubated 24 h before adding the antimicrobial to be tested. 
Treating the cultures with antimicrobials at the same time the myco-
3 bacterial suspension was pulsed with [ H]uracil was labor saving, 
eliminated one more chance to introduce contamination, and produced no 
results different from those obtained when cultures were treated with 
antimicrobials after 24 h incubation. 
Optical density assay for M. avium Results in Table 1 show 
that cultures of M. avium exposed to any one of 6 antimicrobials did 
not have a reduction in absorbance readings equivalent to 1 log less 
than that of nontreated cultures. The effect of 3 antimicrobials on M. 
avium could not be evaluated because of dark colored or cloudy 
antimicrobial solutions. Fourteen antimicrobials yielded an absorbance 
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reading of at least 1 log less than the absorbance reading of the 
nontreated cultures. 
Colony forming units assay for M. avium After 3 days treatment 
in the nephelo culture flasks, there was a difference of 2 logs between 
the numbers of colonies from the nontreated and treated cultures in 27 
(87%) of the 31 assays of antimicrobials tested by the CFA. The 
difference was less than 2 logs in 13% of the treated cultures. While 
these cultures were plated after 3 days exposure to the antimicrobial 
in the nephelo culture flask, the results could not be ascertained 
until after the cultures plated on the agar medium had been incubated 6 
to 8 weeks. Although the cultures were examined with the aid of a 
binocular dissecting microscope, colonies of M. avium required 6 to 8 
weeks incubation to reach a size that could be detected and counted. 
The results of the 3 assays to determine the susceptibility of M. 
paratuberculosis to the antimicrobials are shown in Table 2. 
Rapid radiometric assay for M. paratuberculosis Ten (38.5%) of 
the 26 antimicrobials tested reduced the incorporation of [^H]uracil by 
M. paratuberculosis to 10% or less of the incorporation by the 
untreated control cultures of M. paratuberculosis. In 61.5% of the 
RRAs, M. paratuberculosis incorporated 14 to 100% of the amount of 
3 [ H]uracil incorporated by nontreated controls. 
Optical density assay for M. paratuberculosis Results in Table 
2 show that cultures of M. paratuberculosis individually exposed to 17 
3 
antimicrobials did not have a reduction in incorporation of [ H]uracil 
equivalent to 1 log less than that by nontreated cultures. A 
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difference of 1 log absorbance is equivalent to approximately 2 logs 
CFU (46). The effect on M. paratuberculosis of 4 antimicrobials could 
not be evaluated because of the dark colored antimicrobial solution. 
Cultures of M. paratuberculosis exposed to 6 antimicrobials had a 
reduction in absorbance equivalent to 1 log or more than that of the 
nontreated culture. 
Colony forming units assay After 3 days treatment in the 
nephelo culture flask, there was a difference of 2 logs in the number 
of colonies from the nontreated and treated cultures of M. 
paratuberculosis in 8 (29.6%) of the 27 antimicrobials tested by the 
CFA. The difference was less than 2 logs in 52% of the 27 treated 
cultures. There was a difference of 2 logs of colonies between the 
remaining treated cultures and nontreated cultures after 4 to 13 days 
of incubation. While these cultures were plated after 3 days exposure 
to the antimicrobial in the nephelo culture flask, the results could 
not be ascertained until after the cultures plated on the agar medium 
had been incubated for 12 weeks. Although the cultures were examined 
with the aid of a binocular dissecting microscope, small colonies of M. 
paratuberculosis required 12 weeks of incubation to reach a size that 
could be detected and counted. 
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DISCUSSION 
The use of the ODA techniques to assess the susceptibility of 
slowly growing mycobacteria to antimicrobials was unsatisfactory for 
several reasons. When these species were incubated in liquid culture, 
they formed clumps that were not dispersed completely by Tween 80. 
Also, several of the antimicrobials formed cloudy suspensions and some 
others caused dark colored cultures. The turbidity of these cultures 
was difficult to measure in the spectrometer. In a liquid system where 
long incubation periods are required for growth, a few resistant 
microorganisms can multiply and give the appearance of a resistant 
strain (19). This may explain why a large number of the cultures in 
the optical density assay never showed a difference of 1 log in absor-
bance from the nontreated cultures. Treatment times using the RRA and 
the CFA are short enough to avoid this problem. 
When using the RRA, I considered the mycobacteria susceptible when 
there were 10% or fewer CPM in the treated cultures than in the non-
treated cultures. When using the CFA, I considered the mycobacteria 
susceptible when there was a difference of 2 logs of colonies between 
the treated and nontreated cultures after 3 days exposure to the anti­
microbial. 
M. avium was more susceptible to antimicrobials than M. 
paratuberculosis. Over three-quarters of the RRAs to determine the 
susceptibility of M. avium had 10% or less incorporation while less 
than half of the RRAs to determine the susceptibility of M. 
paratuberculosis had similar percentages of incorporation. 
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After 3 days exposure to the antimicrobials, the RRA and the CFA 
seemed to yield comparable results in determining susceptibility of M. 
avium to 31 assays of antimicrobials. Using the RRA, 23 (74%) of the 
3 treated cultures had 10% or less incorporation of [ H]uracil than the 
nontreated cultures. Using the CFA, 27 (87%) of the treated cultures 
showed a 2 log difference in CFU from the nontreated cultures. 
I compared the susceptibility of M. avium in 30 assays of 
antimicrobials in the CFA and the RRA. There was 83.3% agreement; M. 
avium was susceptible in 22 assays of the antimicrobials and resistant 
in 3 assays of the antimicrobials. M. avium was susceptible in the RRA 
but resistant in the CFA to 1 antimicrobial, and resistant in the RRA 
but susceptible in the CFA to 4 antimicrobials. Snider and associates 
3 
reported that the CDC coordinated an evaluation of the [ H]uracil 
procedures to determine susceptibility of M. tuberculosis. There was 
64% agreement with the agar dilution assay recommended by the CDC. 
Agreement at the 90 to 95% level is considered good (41). 
The RRA and the CFA also yielded comparable results in determining 
susceptibility of M. paratuberculosis to 27 antimicrobials. Using the 
RRA, 10 (38.5%) of the treated cultures had 10% or less incorporation 
3 
of [ H]uracil than did the nontreated cultures. Using the CFA, 8 (30%) 
of the treated cultures showed a difference of 2 logs of CFU from the 
nontreated cultures after 3 days treatment. 
I compared the susceptibility of M. paratuberculosis after 3 days 
exposure to 26 antimicrobials common to both assays, the CFA and the 
RRA. There was 69. 2% agreement; M. paratuberculosis was susceptible 
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in both assays to 5 antimicrobials and resistant in both assays to 13 
antimicrobials. M. paratuberculosis was susceptible in the RRA, but 
resistant in the CFA to 5 antimicrobials, and resistant in the RRA but 
susceptible in the CFA to 3 antimicrobials. 
Snider and associates reported there was 88% agreement between the 
CO^ procedure and the agar dilution assay performed by the CDC to 
determine susceptibility or resistance of M. tuberculosis. They also 
reported there was 64% agreement between the assay using incorporation 
3 
of [ H]uracil and the agar dilution assay performed by the CDC to 
determine susceptibility of M. tuberculosis (41). 
3 The assay using the incorporation of [ H]uracil which Snider and 
associates evaluated was developed by McDaniel and associates. %en 
treated cultures showed 50% of the CPM obtained from nontreated 
cultures, McDaniel and associates considered the antimicrobials 
effective (31). This guideline was adopted from the CO^ procedure 
reported by DeBlanc and associates (11). 
If I had used this criterion for the research reported here, 28 
(93.3%) of the antimicrobials in 30 RRAs would have been considered 
effective against M. avium. Eighteen (69.2%) of the antimicrobials in 
26 RRAs would have been considered effective against M. 
paratuberculosis. This is in contrast to the actual susceptibility of 
M. avium to the antimicrobials in 77% of the RRAs and of M. 
paratuberculosis to the antimicrobials in 38.5% of the RRAs. Such high 
levels of susceptibility (93.3% and 69-2%) would have been inconsistent 
with previous reports (10, 20, 25, 29, 35, 37, 40, 49). 
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The COg procedure produced results on 56.7% of the cultures within 
4 days, 89.1% within 7 days, and 99.7% within 14 days (41). The method 
3 
using [ Hjuracil, reported by McDaniel and associates, allowed results 
to be reported in 48 h (31). The RRA I developed was completed in 3.5 
days. All 3 rapid assays, the RRA, other published assays using 
3 [ Hjuracil, and the CO^ procedure, were more rapid than the CFA. 
While the information on the CFA was based on aliquots sampled 
within a few days of treatment, that information was not available 
until colonies became visible in subcultures after 6 to 12 weeks of 
incubation. If the antimicrobial was bacteriostatic rather than 
bactericidal, the organisms could have recovered when a small inoculum 
was taken from the incubating mycobacterial culture and antimicrobial 
suspension in the nephelo culture flasks and plated on a relatively 
large volume of nontreated solid medium. The concentration of 
antimicrobial would have become very dilute per milliliter of solid 
medium. 
The RRA allows the susceptibility of the mycobacteria to be 
evaluated with only 1 concentration of the antimicrobial in each 
nephelo culture flask. A more efficient procedure would allow a 
variety of concentrations of the antimicrobial to be evaluated simulta­
neously. Then it would be possible to use the same system to determine 
the minimum inhibitory concentration of the antimicrobial for each 
microorganism. 
Results from the RRA reported here compared favorably to the 
currently approved method of agar dilution assays, and the RRA had the 
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advantage of obtaining results 5 to 11 weeks earlier than was possible 
with the agar dilution assay. Therefore, it seems logical to develop 
this RRA. into a system that will permit simultaneous evaluation of 
multiple concentrations of the antimicrobial against M. avium and M. 
paratuberculosis and to determine minimum inhibitory concentrations for 
all antimicrobials to which these mycobacteria are susceptible. With 
the use of a rapid system such as this, one could determine rapidly the 
susceptibility of slowly growing mycobacteria to a large number of 
antimicrobials. 
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SECTION II: DEVELOPMENT OF A RAPID RADIOMETRIC MINIVIAL ASSAY TO 
DETERMINE THE MINIMUM INHIBITORY CONCENTRATIONS OF 
ANTIMICROBIAL AGENTS EFFECTIVE AGAINST MYCOBACTERIUM AVIUM 
AND MYCOBACTERIUM PARATUBERCULOSIS IN VITRO 
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ABSTRACT 
I developed a rapid radiometric assay for determining the suscep­
tibility of 2 slowly growing mycobacteria, Mycobacterium avium and 
Mycobacterium paratuberculosis, to antimicrobial agents. The assay, a 
homogeneous liquid scintillation counting system, utilized the amount 
3 
of [ H]uracil incorporated into the mycobacterial RKA in the presence 
of various concentrations of antimicrobial agents as a measure of the 
inhibitory action of the antimicrobials. Treated cultures that yielded 
fewer counts per minute than did a 1:100 dilution of nontreated myco­
bacteria were considered to be susceptible. The minimum inhibitory 
concentrations were determined for the effective antimicrobials. M. 
paratuberculosis was more refractory than M. avium. 
I conducted the entire assay in the minivials used for counting in 
the liquid scintillation counter. The mycobacterial cells were solu-
bilized to allow the RNA intimate contact with the counting cocktail. 
This assay was completed in 3.5 days, whereas a standard agar 
dilution susceptibility assay for these two mycobacteria requires 6 to 
12 weeks. The rapid radiometric assay reduced the time to determine 
susceptibility of the mycobacteria to antimicrobial agents by 5 to 11 
weeks. 
The assay can be used to determine the susceptibility of a slowly 
growing mycobacterium to a large number of antimicrobial agents and to 
determine the minimum inhibitory concentration of the antimicrobial 
agent. 
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INTRODUCTION 
A number of rapid radiometric procedures to determine the suscep­
tibility of Mycobacterium tuberculosis to antimycobacterial agents have 
evolved over the past decade. The majority of these measure the 
evolution of ^^CO^ from ^^C-labeled substrates (6, 8, 11, 23, 33, 39, 
45, 49). However, a procedure using [^'^Cjuracil developed by White and 
associates, tested the susceptibility of Mycobacterium smegmatis to 
rifampin by measuring the rate of incorporation of [^'^C] uracil into the 
RNA. Later, using the procedures developed by White and associates, 
Benitez and associates, McDaniel and associates, and Kunze and associ­
ates substituted [^Hjuracil for the [^^C]uracil and measured the 
susceptibility of M. tuberculosis to antimicrobial agents (3, 24, 31, 
47). 
3 I developed a rapid radiometric assay using [ H]uracil, and 
compared it to an agar dilution assay and an optical density assay 
(Section I of this dissertation). The rapid radiometric assay evalu­
ated the susceptibility of Mycobacterium paratuberculosis and 
Mycobacterium avium to one concentration of the antimicrobial. There­
fore, the minimum inhibitory concentration (MIC) could not be de­
termined. 
The purpose of this communication is to describe further develop­
ment of the rapid radiometric assay.using the incorporation of 
3 [ H]uracil into the RNA of the same two slowly growing mycobacteria in 
vitro to determine the MIC of various antimicrobials. The technique is 
3 
simpler than previous techniques using the incorporation of [ Hjuracil, 
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requires less handling, and produces a homogeneous liquid scintillât 
counting system. 
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MATERIALS AND METHODS 
3 Radioisotope I added 5-[ H]uracil in sterile water (specific 
activity > 25 Ci/mmol) (New England Nuclear, Boston, MA) to liquid 
medium at a final concentration of 0.5 yCi/ml. Each assay tube, an 
8-ml sterile minivial used in liquid scintillation counters (Isc), 
received 0.13 uCi tritium. Twelve of the 236 assays were conducted 
using 0.6 yCi/ml or 0.15 pCi tritium per minivial. 
Mycobacteria and medium for growth M. paratuberculosis NADC 
21, and M. avium NADC 33, serotype 2, were grown and harvested, and 
aliquots of the organisms were stored at -70°C using the procedure in 
Section I of this dissertation. 
I used Dubos liquid medium (Difco Laboratories, Detroit, MI) (32) 
3 (Appendix A) with ferric mycobactin P (2mg/liter) and [ H]uracil to 
grow the mycobacterial cultures used to determine the rate of 
3 incorporation of [ Hjuracil by mycobacteria. Final concentration of 1. 
4 X 10^ CFU M. avium/ml and 7.8 X 10^ CFU M. paratuberculosis/ml were 
used. 
For use in the radiometric minivial assay, I diluted these organ­
isms with Middlebrook 7H9 liquid medium (7H9) enriched with oleic 
acid-albumin-dextrose-catalase complex (GADC) (100-ml/liter) (Appen­
dix B), Tween 80 (0.5 ml/liter) (Difco Laboratories) ferric mycobactin 
3 P (2 mg/liter) and pulsed with [ H]uracil. Tween 80 is a sorbitan 
polyoxalkalene derivative, and is used as an emulsifier. I made 2 
dilutions of the mycobacteria, the original suspension, and a 1:100 
dilution. 
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Antimicrobial agents The 50 antimicrobials and their sources 
are shown in Tables 1-5. I dissolved the antimicrobials in 7H9 en­
riched with OADC. Water insoluble antimicrobials were put into solu­
tion with 95% ethanol, dimethylsulfoxide, or hydrochloric acid. The 
concentrations of these solvents used in the assays did not inhibit 
3 incorporation of [ Hjuracil by the mycobacteria. I filter-sterilized 
solutions of the antimicrobials through disposable membrane filters 
with 0.22 ym pore size (Millex, Millipore Corp., Bedford, MA). I made 
5 serial 5-fold dilutions of each antimicrobial. To determine the MIC 
of some antimicrobials, I made more dilutions. 
3 Rate of incorporation of [ Hjuracil by the mycobacteria To 
3 
establish the rate of incorporation of [ Hjuracil by M. avium, I 
examined four 500 pi aliquots of nontreated bacterial cultures at 
intervals between 15 min and 9 days. The aliquots were placed in 
4 minivials. Mycobacterial cells in each minivial were killed and 
precipitated with 7-ml 95% ethanol. 
Ethanol-hot water-centrifugation-minivial radioassay procedure 
The rapid radiometric ethanol-hot water-minivial procedure (minivial 
assay) is illustrated in Fig. 1. All procedures were carried out in a 
biological safety cabinet, except for centrifugation and drying the 
cells. 
3 I pipetted equal volumes of the [ HJ uracil-mycobacterial suspen­
sion and the antimicrobial dilution into 4-dram vials. Then I pipetted 
3 
equal volumes of the [ H]uracil-mycobacterial suspension and nontreated 
medium into more 4-dram vials for control cultures. Suspensions 
Table 1. Resistance of M. avium in vitro to 6 antimicrobials 
Animicrobial 
Highest 
concn 
evaluated 
(units/ml) 
// of eval-
Source nations Solvent^ 
Saturated 
solution // CFU/ml 
£-Aminosalicyclic 
acid (PAS), pH 7.4 
3.9 mg 11 2 NK^ 4X10^ 
Cefazolin sodium 210 Pg 3^ 1 NR 8X10^ 
Lauricidin plus F 100 Ug 1 1 1.2% ethanol NR 8X10^ 
Lauricidin plus III 100 Vè 1 1 0.7% ethanol NR 8X10^ 
Pyrazinamide (PZA), 
pH 7.4 
9.7 mg 11 1 NR 4X10^ 
PZA, pH 5.5 6.9 mg 11 1 HCl NR 8X10^ 
Trimethoprim 280.5 Pg 11 1 15% ethanol no 8X10^ 
^Numbers refer to sources in Table 5. 
^7H9, OADC, Tween 80 and ferric mycobactin P unless otherwise noted. Final concn of solvent 
at highest concn of antimicrobial evaluated. 
^Not recorded. 
^Gift from source listed. 
Table 2. Susceptibility of M. avium in vitro to 42 antimicrobials 
Reported 
concn. 
MIC ^ il of eval- ^ in vivo^ 
Antimicrobial (units/ml) Source uations Solvent // GFU/ml (units/ml) 
Amikacin sulfate 200 Jig 2 1 4X10^ 20 pg 
£-Aminosalicyclic acid 399 pg 11 1 8X10^ 75 pg 
(PAS), pH 5.5 «; A 
Bacitracin 58.8 units 11 1 8X10 r NA 
Capreomycin sulfate 17.2 pg 3, 11 3 1 at 4X10^ 
2 at 8X10^ 
(MIC from 
8X10^) 
NA 
Carbenicillin 16.7 pg 11 ;L 4X10^ 15-20 pg 
Cefoxitin sodium 207 pg 8 2 1 at 8X10 
(MIC from 
4X10 ) 
20 pg 
Cephalexin 416.5 pg 3® 2 1 at 8X10 18 pg 
(MIC at 
4X10 
35 pgf Cephaloridine 35 pg 3® 3 2 at 8X10 
(MIC from 
4Xir) 
Cephapirin sodium 125 pg 2 1 4X10^ 10-20 pg 
Cephadrine hydrate 0.8 mg 12® 1 8X10^ 10-18 pg 
pH 8.0 S 
Chloramphenicol 175 pg 11 J. 4X10^ 10-15 pg' 
Chlortetracycline 200 pg 1 1 4X10 3 Pg^ 
HCl 
987.6 pgj 
t; 
Cloxacillin 11 2 1 at 4X10 
(MIC from 
8X10 ) 
10 pg 
D-cycloserlne 80 pg 11 2 8X10 30 pg 
Dlcloxaclllln 394 ng 11 2 8X10^ 5-10 pg 
Erythromycin 2.3 pg 11 2 4X10 ^ 0.5 yg^ 
lithambutol HCl 664.9 wg 7a® 2 1 at 8X10^ 
(MIC from 
4X10 ) 
5 (ig 
^Numbers refer to sources in Table 5. 
'^7H9, GADC, Tween 80 & ferric mycobactin P unless otherwise noted. Where noted, the final 
concn of the solvent is at the highest concn of the antimicrobial evaluated. 
^In human plasma except where noted (See references cited: 2, 21, 38). 
^Not available. 
Ui 
e °° 
Gift from source listed. 
^Blood Instead of plasma. 
^Animal blood. 
^Animal serum. 
^Veterinary product. 
•^Intermediate susceptibility. 
Table 2 (continued) 
MIC 
Antimicrobial (units/ml) Source 
Ethionamide , 3.8 pg 13, 14^ 
Gentamlcln sulfate 8 ug 10 
Isonlcotinlc acid 5.8 pg 11 
hydrazine (INH) 
Kanamycin acid sulfate 7.1 wg 11 
Kanamycin sulfate 18.7 yg 2 
Laurie acid^ 2 mg 11 
Laurlcidin^ 400 wg 5 
Lincomycin 0.13 units = 11 
110.5 mg 
Lividomycin sulfate 65 pg 6 
Minocycline HCl 3.4 pg 11 
Neomycin sulfate 8.6 pg 11 
Novobiocin 2.4 pg 11 
Oleandomycin phosphate 14.4 pg 11 
Oxytetracycline 62.5 pg 11 
dihydrate 
Reported 
concn. 
# of eval- , i^ vivo^ 
nations Solvent It CFU/ml (units/ml) 
2 8X10^ 20 pg 
2 4X10^ 4-16 pg* 
8X10^ 
2 1 at 4X10 3-5 pg 
(MIC from 
8X10 ) 
2 1 at 4X10^ 4-32 pg" 
(MIC from 
8Xlcf) 
2 1 at 4X10^ 4-32 pg" 
(MIC from 
8X10^) 
1 1.95% 4X10 NA 
ethanol 
0.86% 
ethanol 
6% 4X10* NA 
8X10^ 15-20 pg 
3 1 at 4X10 NA 
(MIC from 
8Xir) 
1 WXlOq 3 pg 
1 8X10^ 1-4 pg 
2 8X10^ NA 
1 4X10^ NA 
1 4X10^ 3 pg 
Oxytetracycllne HCl 25 pg 11 
Oxytetracycline 62.5 pg 9 
injectable 
Penicillin G potassium 240 units 9 
Piperacillin sodium 533.3 \ig 7b 
Polymyxin B sulfate 8,022 units 11 
Rifampin 2.5 pg 11 
Spiro-piperidyl 0.1 pg 4^ 
rifamycin (LM427) 
Streptomycin sulfate 4.2 pg 3 
Tetracycline HCl 49 pg 11 
Tobramycin sulfate 6.4 pg 3 
Viomycin sulfate 133 ug 9 
k Animal plasma. 
^7H9 with ADC rather than OADC. 
""Serum instead of plasma. 
"^Achievable level variable 
°1 on 7H9 with ADC, remainder on 7H9 with OADC 
2 1 at 4X10^ 3 ng 
(MIC from 
8X10") 
2 1 at 8X10^ 50 pg 
(MIC from 
4X1Q>) 
1 4X10^ 0.5 units 
2 8X10^ 775 pg" 
2 8X10^ 59,200 units 
1 BXlOq 7 pg 
1 0.2% 8X10 0.5 pg 
DMSO 
4 1 each at ^ 25-30 pg 
4X10 ,4X10 
2 at 8X10^ 
(MIC from 
BXlgS) 
1 8X10 1.5-4 pg 
2 1 at 4X10^ 5-8 pg o 
1 at 8X10^ 
1 8X10^ NA 
Table 3. Resistance of Mycobacterium paratuberculosis in vitro to 27 antimicrobials 
Highest 
concn 
evaluated ^ it of eval- ^ Saturated 
Antimicrobial (quantity/ml) Source nations Solvent solution // CFU/ml^ 
£-Aminosalicyclic 3.9 mg 11 2 NR 
acid (PAS), pH 7.4 
Bacitracin 293.7 units 11 1 NR 
Capreomycin sulfate 166.7 mg 3,11 2 yes 
Cephalexin 16.7 mg 3® 3 NR 
Cephaloglycin 3.7 mg 3 1 yes 
Cephaloridine 143 mg 3® 4 NR 
Cephalothin sodium 128.3 mg 3 3 yes 
Cephapirin sodium 625 yg 2 1 NR 
Cephradine hydrate 20.5 mg 12® 1 NR 
pH 8.0 
Chloramphenicol 875 ng 11 1 NR 
Dicloxacillin 1.9 mg 11 1 NR 
Doxycycline hyclate 86 pg 9 1 NR 
Kanamycin acid 275 mg 11 2 yes 
sulfate 
Kanamycin sulfate 67 mg 2 2 yes 
Lauricidin plus F 100 tjg 5® 1 1.2% ethanol NR 
Lauricidin plus 111 100 pg 5® 1 0.72% ethanol NR 
Lincomycin 18 ,648 units 11 2 Yes 
Lividomycin sulfate 650 mg 6® 2 NR 
Minocycline HCl 17.1 Mg 11 1 no 
Neomycin sulfate 5.4 mg 11 1 no 
Novobiocin 59.5 Mg 11 1 NR 
1 at p 
2.4X10" 
1 at c 
2.4X10" 
6X10^ 
Oleandomycin 1.8 mg 
phosphate 
Pyrazinamide (PZA), 9.7 mg 
pH 7.4 
PZA at pH 5.5 6.9 mg 
Streptomycin sulfate 9.7 mg 
Tetracycline HCl 245 pg 
Trimethoprim 280.5 pg 
Viomycin sulfate 83.3 mg 
11 
11 
11 
3 
11 
11 
9 
1 
4 
1 
2 
1 
HCl 
no 
NR 
yes 
NR 
15% ethanol 
yes 
no 
NR 
1 at c 
2.4X10* 
1 each(.at 
1.2X10^, 
2.4X10^. 
2 at r 
4.8X10 
^Numbers refer to sources in Table 5. 
^7H9, OADC, Tween 80 and ferric mycobactin P unless otherwise noted. Where noted, the final 
concn of the solvent is at the highest concn of the antimicrobial evaluated, 
c 5 
4.8X10 CFU/ml unless otherwise noted. 
^Not recorded. 
^Gift from source listed. 
Table 4. Susceptibility of M. paratuberculosis in vitro to 24 antimicrobials 
Reported 
concn. , 
MIC ^ il of aval- ^ iji vivo 
Antimicrobial (units/ml) Source^ nations Solvent // CFU/ml^ (units/ml) 
Amikacin sulfate 25 mg 2 2 
£-Aininosalicyclic acid 2 mg 11 1 
(PAS) pH 5.5 
Carbenicillin 65.7 (jg 11 2 
Cefazolln sodium 243 mg 3® 2 
Cefoxitin sodium 33.3 mg 8 2 
Chlortetracycline 
HCl® 
250 wg 1 2 
Cloxacillin 24.7 mg 11 2 
D-cycloserine 34.3 mg 11 2 
Erythromycin 18.6 mg 11 3 
Ethambutol HCl 253.9 mg 7 a® 2 
Ethionamide 2.4 mg 13, 14 2 
Gentamicin sulfate^ 5 mg 10 1 
Isonicotinic acid 727 Jjg 11 2 
hydrazine (INH) 
Laurie acid 0.4 mg. 11 
l.auricidin 0.4 mg'^ 5® 
Oxytetracycline 250 lig 11 
dihydrate 
Oxytetracycline HCl 250 pg 11 
Oxytetracycline 250 pg 9 
injectable® 
Penicillin G potassium 30,000 units 9 
Piperacillin sodium 333.35 mg 7b 
Polymyxin B sulfate 200,540 units 11 2 
1 at 6X10 
1 at 6X10 
1 at 2.4X10" 
1.2X10^ 
1.2X10 
20 lig 
75 )jg 
15-20 pg 
64 (Jg 
20 lig. 
3 pg 
10 wg 
30 Pg . 
0.5 ug" 
5 Mg 
l-ïe .g" 
3-5 lig 
NA^ 
NA 
1.5-4 Më 
1.5-4 wg^ 
50 pg" 
0.5 unit^ 
775 ug"* 
59,200 units 
Rifampin 2.5 yg 11 1 0.009% 7 (Jg 
DMSO" 
Spiro-piperidyl 0.5 pg 4^ 1 0.2% 0.5 yg 
rifamycin (LM427) DMSO 
Tobramycin sulfate 20 mg 3 1 5-8 pg 
^Numbers refer to sources in Table 5. 
GADC, Tween 80 & ferric mycobactin P unless otherwise noted. Where noted, the final 
concn of the solvent is at the highest concn of the antimicrobial evaluated. 
c 5 4.8X10 unless otherwise noted. 
^In human plasma except where noted (See references cited: 2, 21, 38) 
^Gift from source listed. 
^Animal serum. 
^Veterinary product. 
^Animal plasma. 
^Information not available. 
^Intermediate susceptibility. 
^Animal blood rather than human plasma. 
^Blood instead of plasma. 
"serum instead of plasma. 
^Dimethyl sulfoxide. 
Table 5. List of sources for antimicrobial agents 
Reference //^ Source 
1 American Cyanamld 
Princeton, NJ 
2 Bristol Laboratories 
Syracuse, NY 
3 Eli Lilly & Co., 
Indianapolis, IN 
Farmitalia Carlo Erba 
Milan, Italy 
Jon J. Kabara, Ph.D. 
College of Osteopathic Medicine 
Michigan State University 
East Lansing, MI 
6 Kowa Co., Ltd. 
Nagoya, Japan 
7a Lederle Laboratories Division 
American Cyanamld 
Pearl River, NY 
7b Lederle Laboratories 
Wayne, NJ 
8 Merck, Sharp and Dohme 
West Point, PA 
9 Pfizer Laboratories Division 
Pfizer, Inc. 
New York, NY 
10 Schering Corporation 
Kenilworth, NJ 
11 Sigma Chemical Co. 
St. Louis, MO 
12 Squibb Institute for 
Medical Research 
Princeton, NJ 
13 Ives Laboratories, Inc. 
685 Third Avenue 
New York, NY 
14 Wyeth Laboratories, Inc. 
Philadelphia, PA 
^Source of antimicrobials identified by this number in 
Tables 1 to 4. 
Fig. 1. Ethanol-hot water-centrifugation-minivial procedure for 
the rapid radiometric assay procedure to determine susceptibility of M. 
paratuberculosis and M. avium to antimicrobial agents 
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TREATED TEST CULTURES NONTREATED CONTROLS 
Mycobacteria stored at —70°C inocu— Mycobacteria stored at —70°C inocu­
lated into liquid culture medium lated into liquid culture medium 
containing [ H] uracil, and com— containing [ H] uracil, and combined 
bined -witlx equal volumes of 5, 5— with equal volumes of liquid culture 
fold dilutions of antimicrobial medium. Repeated with, a 1:100 dilu— 
agents into 4—dram vials. tion of mycobacteria. 
0.5 ml pipetted into 8-ml liquid scintillation counting vials 
Incubated^68h.. ST^C 
I 
Cells killed and precipitated with 7-ml 95% ethanol 
1 
Centrifuged 20 min at 890 x g 
1 
3 hot (9^ C) water washes (5-ml) by centrifugation 
Cells dried 72°C 
I 
Cooled cells rehydrated with 50—ul 0.5% Tween 80 
Cells solubilized in 0.5 ml tissue solubilizer at 54 °C for 3h 
1 
5-ml counting cocktail 
2h Standing time 
Count in liquid scintillation counter 
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(0.5 ml) were pipetted from the 4—dram vials into 20 sterile minivials 
for each antimicrobial evaluated. This was repeated for each 
antimicrobial and mycobacterium evaluated. I usually evaluated the 
susceptibility of both mycobacteria to 3 antimicrobials each time I 
conducted a minivial assay. Eight minivials of nontreated bacteria and 
8 minivials of the 1:100 dilution of the nontreated bacteria were used 
for controls for a total of 16 minivials. There were 2 117,000 counts 
per minute (CPM) available in each minivial. The minivials were 
incubated for 68 h at 37°C without shaking. 
After incubation, the cells in each minivial were killed and 
precipitated with 7-ml ethanol (95%). The minivials were placed in 
17-place, 3/4 inch trunnion carriers held by a 4-place, pin-type 
horizontal rotor, and were centrifuged 20 min at 890 x g without 
refrigeration (International portable centrifuge, model PR-2). The 
ethanol was decanted, a 5 ml volume of hot water (95°C) was added to 
each minivial, and the minivials were centrifuged as before. The hot 
water wash was repeated 2 times for a total of 3 washes. At times, the 
hot water was added to the minivials about 20 to 30 min in advance of 
centrifuging. The killed mycobacterial cells were dried in a 72°C 
ventilated oven. When cooled to roon "en-perature, the cells in each 
minivial were rehydrated 20 to 30 min with 50 pi 0.5% Tween 80, and 
then were solubilized in 0.5 ml tissue solubilizer (Soluene-350, 
Packard Instrument Co., Downers Grove, IL) at 54°C for 3 h. 
Solubilization of the cells allowed for a homogeneous liquid 
scintillation counting system. 
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I added 5-ml of scintillation counting cocktail (Liquifluor, New 
England Nuclear) to each minivial after solubilization of the myco­
bacterial cells. After standing 2 h to allow for resolution of chemi-
luminescence, I measured the radioactive decay of the tritium in each 
minivial for 2 min in a Isc (Beckman LS8000). Background count was 
approximately 20 CPM; the machine counted at 63% efficiency. 
Interpretation of the minivial assay Mycobacteria from mini-
vials of treated cultures with more CPM than those of the nontreated 
1:100 dilution of mycobacteria were considered resistant to the anti­
microbial. Mycobacteria from the minivials of treated cultures with 
fewer CPM than those of the nontreated 1:100 dilution of mycobacteria 
were considered susceptible to the antimicrobial (41). Those treated 
and nontreated cultures in minivials with equal numbers of CPM were 
considered to have intermediate susceptibility. The MIC was the lowest 
concentration of the antimicrobial to which the mycobacteria were 
susceptible. 
The 1:100 dilution represents 1% of the mycobacterial population. 
This 1% level of resistance in a population is significant. Extensive 
chemotherapy trials on patients with tuberculosis have indicated that 
when 1% of the population of mycobacteria is resistant to a certain 
concentration of the antimicrobial, then that antimicrobial is not, or 
soon will not be useful for chemotherapy. The 1% of the population of 
mycobacteria quickly becomes the predominant form and approaches 100% 
of the population (19). 
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RESULTS 
3 Rate of incorporation of [ H]uracil by the mycobacteria The 
3 
results of the incorporation of 0.5 yCi [ H]uracil by M. avium and M. 
paratuberculosis over 50 h are shown in Fig. 2., Incorporation of 
3 [ H]uracil by both mycobacteria increased rapidly for up to 10 h, and 
continued to increase through 30 h for M. paratuberculosis and longer 
for M. avium. By 6 days the CPM had dropped about 8% from the values 
shown at 50 h and remained there through the 9 days of observation. 
Essentially, incorporation was completed in 2 days. I selected 68 h as 
3 the length of time to allow the cultures to incorporate [ H]uracil in 
the presence or absence of the antimicrobial. I wanted to be able to 
terminate both mycobacterial cultures at the same time, and it seemed 
this length of time would accommodate cultures that might have grown a 
little more slowly. This schedule permitted completing the suscep­
tibility assays of both mycobacteria to 6 antimicrobials per week. 
Susceptibility of mycobacteria Figure 3 illustrates the 
susceptibility of M. avium and M. paratuberculosis to isonicotinic acid 
hydrazide (INH). This curve was representative of susceptibility 
curves obtained using the minivial assay with other antimicrobials to 
which the mycobacteria were susceptible. The MIC of INH for M. 
paratuberculosis was 727 pg/ml. As shown in Fig. 3, the MIC is the 
lowest concentration of INH below the line of effectiveness, the 
horizontal line marking the number of CPM from the nontreated 1:100 
dilution of M- paratuberculosis. 
3 S 
Fig. 2. Incorporation of [ H]uracil by 1.4 X 10 CFU M. avium/ml 
Dubos broth medium, and by 7.8 X 10^ CFU M. paratuberculosis/ml Dubos 
broth medium with ferric mycobactin P. Symbols: 0——0, H. avium; 
A A, M. paratuberculosis 
INCORPORATION OF PHI URAClL(Kcpm) 
3 Fig. 3. Effect of INH on incorporation of [ H]uracil by M. avium 
and M. paratuberculosis. Symbols: 0 0, M. avium; A A ,  M. 
paratuberculosis 
^This line indicates the CPM from the 1:100 dilution of the 
corresponding nontreated bacterial suspension. The corresponding 
mycobacterium was susceptible to all concentrations of INH below 
line "a." The MIC is the lowest concentration below the line. 
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The MIC of INH for M. avium, 5.8 yg/ml, was calculated in the same 
manner. 
Resistance of organisms Figure 4 illustrates the resistance of 
the mycobacteria to p;-aminosalicyclic acid. The CPM for both treated 
mycobacteria exceeded the CPM for the nontreated 1:100 dilution of 
mycobacteria. This curve is representative of resistance curves using 
the minivial assay with other antimicrobials to which the mycobacteria 
were resistant. 
M. avium was resistant to 6 antimicrobials (Table 1), and suscep­
tible to 42 antimicrobials (Table 2). M. paratuberculosis was resis­
tant to 27 antimicrobials (Table 3) and susceptible to 24 anti­
microbials (Table 4). 
Concentrations of antimicrobials in vitro Although M. 
paratuberculosis was susceptible to 24 of the antimicrobials, only 
rifampin and spiro-piperidyl rifamycin (LM427) had MIC (2.5 and 0.5 
pg/ml) less than or equal to the level (7 and 0.5 yg/ml) achievable in 
human blood, plasma, or serum. 
Twelve of the 42 antimicrobials to which M. avium was susceptible, 
had MIC less than or equal to the levels of antimicrobials achievable 
in humans. They were ethionamide, gentamicin, rifampin, spiro-
piperidyl rifamycin (LM427), tobramycin sulfate, kanamycin acid sul­
fate, kanamycin sulfate, streptomycin sulfate, cephaloridine, carbeni-
cillin, piperacillin sodium and polymixin B sulfate. The information 
was unavailable for another 6 antimicrobials to which M. avium was 
3 Fig. 4. Effect of PAS on incorporation of [ Hjuracil by M. avium 
and M. paratuberculosis. Symbols : 0 0, M. avium; A A, M. 
paratuberculosis 
^This line indicates the CPM from the 1:100 dilution of the 
corresponding nontreated mycobacterial suspension. PAS is not 
effective; to be effective, there would have to be at least one 
concentration of PAS below the line. 
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susceptible. The MIC for minocycline was only 0.4 pg higher than the 
published level achievable in human plasma. 
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DISCUSSION 
I determined the susceptibility of M. avium to 24 antimicrobials 
using both the rapid radiometric assay reported in Section I of this 
dissertation, and the minivial assay. There was 87.5% agreement. M. 
avium was susceptible to 18 antimicrobials in both the rapid radio­
metric and minivial assays, and resistant to 3 in both assays. M. 
avium was susceptible to 1 antimicrobial in the minivial assay and 
resistant to the same one in the rapid radiometric assay, and resistant 
to 2 antimicrobials in the minivial assay, but susceptible to them in 
the rapid radiometric assay. 
There was 5% less agreement (82.6%) between the minivial and the 
CFA of the susceptibility of M. avium reported in Section I of this 
dissertation. 
Agreement between the assays for the susceptibility of M. 
paratuberculosis to antimicrobials was not as high. I determined the 
susceptibility of M. paratuberculosis to 26 antimicrobials common in 
both the rapid radiometric assay reported in Section I, and the mini­
vial assay. There was 76.9% agreement. M. paratuberculosis was 
susceptible to 8 antimicrobials in both the rapid radiometric and 
minivial assays, and resistant to 12 more in both assays. M. 
paratuberculosis was susceptible to 4 antimicrobials in the minivial 
assay and resistant to them in the rapid radiometric assay, and 
resistant to 2 antimicrobials in the minivial assay, but susceptible to 
them in the rapid radiometric assay. 
81 
There was about 14% less agreement (63%) between the minivial and 
the agar dilution assays of the susceptibility of M. paratuberculosis 
reported in Section I. 
Snider and associates suggested that a desirable level of 
agreement between the agar dilution assay and the radiometric assay for 
M. tuberculosis would be 90 to 95% (41). It would be desirable to 
increase the levels of agreement I found for M. avium and for M. 
paratuberculosis. However, there have been a minimum of reliable 
investigations on the susceptibility of M. paratuberculosis in agar 
dilution assays, and so there is no real base for comparison (33, 40). 
The data on the susceptibility of M. paratuberculosis in agar dilution 
assays in Section I of this dissertation represent the largest study of 
this kind to date. Even if sufficient data for the susceptibility of 
M. paratuberculosis existed, one should be cautioned against assuming 
they would be valid because of the long incubation (12 weeks) required. 
One of the advantages of the minivial assay over conventional agar 
dilution assays is the ability to increase the concentration of the 
antimicrobial. In the agar dilution assays, the most concentrated 
dilution of the antimicrobial is distributed in a plate of agar medium. 
However, in the minivial assay, I mixed the most concentrated 
antimicrobial dilution with an equal volume of the suspension of 
mycobacteria. This allows the minivial assay to be conducted using a 
higher concentration of the antimicrobial than on the agar dilution 
assays. 
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Snider and associates reported that McDaniel's and associates' 
assay was cumbersome (41). The minivial assay I developed used 
minivials for the entire procedure. The assay cultures were 
established in the minivial and the mycobacterial cells remained in the 
minivial throughout incubation, processing, and the counting procedure 
in the Isc. The procedure of minimal handling is desirable also 
because the mycobacteria are pathogens. 
3 The other procedures using [ Hjuracil, required the collection of 
each assay culture on a filter (3, 24, 31). Filters and the intact 
mycobacterial cells cause quench of weak 3—emitters, such as tritium, 
and form a heterogeneous counting system. With the use of the minivial 
for the incubation of the culture assay as well as the counting proce­
dure, the excessive transferring and handling required for filtering 
cultures were eliminated. 
The time required for the minivial assay, 3.5 days, was comparable 
3 to the 48 h required for another assay using [ Hjuracil (31) and the 1 
14 to 2 weeks required for the rapid radiometric assay using CO^ (41). 
These two assays reported by McDaniel and associates and Snider and 
associates determined the susceptibility of M. tuberculosis, a 
determination which requires 3 to 4 weeks on agar dilution assays (31, 
41). The minivial assay required considerably less than the 6 to 12 
weeks required for an agar dilution assay of the susceptibility of M. 
paratuberculosis and M. avium. 
The times required for these assays are in addition to the length 
of time required to isolate the mycobacteria from the infected host. 
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and then to subculture sufficient quantities of the mycobacteria for 
the assay. The average total time for an agar dilution assay of the 
susceptibility of M. paratuberculosis requires 12 or more weeks to 
isolate the mycobacteria, 8 to 12 weeks to subculture in sufficient 
quantity to perform an assay, and another 12 weeks for the results of 
the assay. If sufficient growth is present on the primary isolation to 
use in the assay, it may be possible to avoid the subculture procedure. 
The minivial assay avoids the 12 weeks of incubation required for the 
determination of susceptibility of M. paratuberculosis to anti­
microbials in the agar dilution assay. 
The times required for M. avium are shorter. The primary isola­
tion of M. avium requires 6 to 8 weeks, the subculture another 4 to 6 
weeks, and the agar dilution assay another 6 weeks. If sufficient 
growth is available from the primary isolation, it may be possible to 
avoid the subculture procedure. The minivial assay avoids the 6 weeks 
of incubation required to determine susceptibility of M. avium to 
antimicrobials in the agar dilution assays. 
It is possible that the incubation period of the minivial assays 
could be shortened. Cultures of M. paratuberculosis had reached the 
plateau stage of incorporating uracil between 25 and 30 h and M. avium 
by 48 h (Fig. 2). 
The rapid radiometric minivial assay reported here deserves 
further evaluation. It uses more reliable liquid scintillation 
counting techniques that the other rapid radiometric assays using 
3 [ Hjuracil (3, 24, 31). It uses safer handling methods for pathogens 
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by conducting the entire assay in the minivial. The other procedures 
require handling the cultures to filter them. The minivial assay is 
considerably more rapid than the lengthy assay period for agar dilution 
assays. It is also a method by which a large number of antimicrobials 
could be screened to determine potential effectiveness against slowly 
growing mycobacteria, and to determine the MIC of the antimicrobials. 
Certainly, the antimicrobials at concentrations achievable in blood 
that were found effective against the mycobacteria in this study would 
be logical first choice selections to use in in vivo studies. 
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SUMMARY AND DISCUSSION 
The objective of this research project was to determine if a rapid 
radiometric assay (RRA) could be developed for detecting the 
susceptibility of slowly growing mycobacteria, Mycobacterium 
paratuberculosis and Mycobacterium avium, to antimicrobial agents. 
After the assay was developed, I compared it to currently acceptable 
techniques for determining susceptibility of microorganisms. 
The RRA compared favorably to the colony forming units assay 
(CFA), a modified agar dilution assay. When I compared the nontreated 
cultures from the RRA and the CFA, there was a linear relationship. 
Both methods were valid measurements of growth of the mycobacteria. 
An agar dilution assay is the currently recommended assay to 
determine susceptibility of Mycobacterium tuberculosis. I modified and 
developed the RRA into the ethanol-hot water-centrifugation minivial 
assay (minivial assay) that was capable of determining the 
susceptibility of the mycobacteria to antimicrobials and the minimum 
inhibitory concentration (MIC) of effective antimicrobials. 
To compare results of the minivial assay and the RRA, one needs to 
be aware of the differences between the two assays. The minivial assay 
was a stationary culture with which I evaluated the response of M. 
avium and M. paratuberculosis, after 68 h exposure, to 5 concentrations 
of each antimicrobial. Minimum inhibitory concentrations were 
determined for the antimicrobials that were effective against the 
mycobacteria. The RRA was a shaken culture with which I determined the 
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susceptibility of the mycobacteria, after 3 days treatment, to one 
concentration of each antimicrobial tested. Numbers of microorganisms, 
concentrations of antimicrobials, volumes of the cultures, and diluents 
used for the antimicrobials varied between these 2 assays. The CFA was 
conducted using treated and nontreated cultures from the RRA. 
The susceptibility of M. avium to 24 antimicrobials was determined 
using both the minivial assay and RRA. There was 87% agreement between 
the 2 assays. I made the comparison using the criteria established to 
determine susceptibility or resistance by the RRA (Section I of this 
dissertation) and the MIC by the minivial assay (Section II). 
Mycobacterium paratuberculosis was more refractory to anti­
microbials than was M. avium. The susceptibility of M. para­
tuberculosis to 26 antimicrobials was determined using both the RRA 
and minivial assay. There was 76.9% agreement between the 2 assays. 
A technique published by DeLand and Wagner automatically detected 
14 
microbial growth and metabolism by measuring the evolution of CO2 
14 from the metabolism of C-labeled glucose in an ion chamber device 
(15). Later, Middlebrook and associates applied this method to the 
early detection of the growth of Mycobacterium tuberculosis by 
measuring the produced by metabolism of [^^C]palmitic acid in an 
automated ionchamber device, the Bactec instrument (Johnston 
Laboratories, Cockeysville, MD) (33). This has been developed into an 
assay technique to determine the susceptibility of mycobacteria and is 
known as the CO^ procedure (41). In this procedure, the bacteria were 
grown in 7H12 liquid culture medium, a medium consisting of 7H9 
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(Appendix B) with 0.1% "vitamin free" enzymatic hydrolysate of casein 
and a combination of catalase and antimicrobials (amphotericin B, final 
concentration 5 pg/ml; polymyxin B, 50 yg/ml; carbenicillin, 25 ug/ml; 
and trimethoprim, 2.5 yg/ml). 
I found M. avium susceptible to carbenicillin at 16.7 pg/ml using 
the minivial assay. This level was less than the final concentration 
of carbenicillin in Middlebrook's CO^ procedure. This datum emphasizes 
the differences among mycobacteria, and the need to evaluate the 
requirements and tolerances of each species within the genus before 
using an assay system developed for 1 species of Mycobacterium on a 
different species of Mycobacterium. Except for the antimicrobials 
being tested, I used no antimicrobials in the media for the RRA or the 
minivial assay. 
Siddiqi and associates reported 98% agreement between the CO^ 
procedure in the Bactec instrument and the agar dilution method. If 
there was disagreement, more often the radiometric method showed the 
strain susceptible and the agar dilution method showed the strain 
resistant (39). 
I compared the results from 2 combinations of assays which I 
developed for evaluating the susceptibility of M. paratuberculosis. 
The agreement between the CFA and RRA was 69.2%; the disagreement was 
equally divided among the antimicrobials. When I compared the CFA and 
minivial assays, there was 63% agreement; there were 10 antimicrobials 
in disagreement. M. paratuberculosis was susceptible to 7 (70%) of the 
10 antimicrobials using the minivial assay, but resistant to the 
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same 7 on the CFA. There were 3 antimicrobials to which M. 
paratuberculosis was resistant using the minivial assay, but 
susceptible when using the CFA. 
When I compared the results for M. avium, I found 83.3% agreement 
between the RRA and CFA, and 5 antimicrobials in disagreement. Four 
were resistant in the RRA, but susceptible using the CFA, 1 was 
susceptible on the RRA, but resistant using the CFA. There was 82.6% 
agreement between the minivial and CFA. The 4 in disagreement were all 
susceptible on the CFA, but resistant on the minivial assay. 
However, one cannot assume that the agar dilution assay is the 
most reliable assay because it is the assay with the longest history of 
use. When prolonged incubation of the test cultures are required, 
unreliable results may occur (19, 37, 44). While growth may occur, it 
may be growth of a susceptible strain that is allowed to grow in the 
presence of an inactivated or partially active antimicrobial (7, 44). 
I defined the level of susceptibility in the minivial assay as 
that number of CPM that was less than the number of CPM from a 1:100 
dilution of the mycobacteria or 1% of the population in a nontreated 
culture (41, 44). Antimicrobial susceptibility of M. tuberculosis in 
the other assay procedures using (^Hjuracil was defined as that number 
of CPM from treated cultures equal to or less than 50% of the CPM from 
the control cultures (3, 11, 23, 41). This criterion was developed 
originally by DeBlanc and associates for use with the CO^ procedure 
(11). There could be considerable difference between the CPM from 1% 
of the nontreated population and from 50% of the CPM from 100% of the 
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population- Certainly, the 1% guideline I used was much more stringent 
than the 50% guideline used to determine susceptibility with the other 
3 [ Hjuracil procedures. This difference in definition of susceptibility 
may account for the greater differences in agreement I found between 
the minivial assay and the CFA. I found 82.6% agreement between the 
CFA and minivial assays of the susceptibility of M. avium to 23 
antimicrobials, and 63% for M. paratuberculosis to 27 antimicrobials. 
Although McDaniel did not report a percentage of agreement, he reported 
excellent agreement between the agar dilution and rapid radiometric 
assays of 3 antimycobacterial agents (41). 
A comparative study of the CO^ procedure, developed by Middle-
3 brook and associates, and the [ Hjuracil procedures, developed by 
McDaniel and associates and by Kunze and associates, was coordinated by 
Snider and associates at the Centers for Disease Control (CDC) (41). 
3 They reported that the [ Hjuracil assay showed poor agreement (64%) 
with the agar dilution assays at the CDC, was cumbersome, and difficult 
to teach. Snider and associates recommended further evaluation and 
refinement of the CO^ assay system developed by Middlebrook and associ­
ates (41) . 
In McDaniel's and associates' procedure, the cultures were 
precipitated with 5% cold trichloracetic acid. The precipitated 
cultures were vacuum filtered through glass fiber filters and then were 
rinsed with additional 5% trichloracetic acid. The filters were placed 
in glass vials and then counted in a Beckman liquid scintillation 
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counter (Isc) for 10 min, or to a total of 10,000 CPM. The results 
were completed in 48 h (31). 
Methods for the rapid radiometric assay McDaniel and associates 
developed for determining susceptibility of M. tuberculosis, and the 
one I developed to determine the susceptibility of M. avium and M. 
paratuberculosis were considerably different. Both methods used the 
3 inhibition of incorporation of [ H]uracil to measure the effect of 
antimicrobials. 
In the minivial assay I developed, I used Middlebrook 7H9 liquid 
medium for dilution of the antimicrobial and growth of the culture. 
McDaniel and associates used a similar medium for cultivation of the 
culture but they did not report the diluent for the antimicrobials 
(31). Before I evaluated 95% ethanol for killing and precipitating the 
mycobacteria, I used cold trichloracetic acid to precipitate cultures, 
but I found the mycobacteria did not stay at the bottom of the minivial 
well enough to permit decanting. McDaniel and associates used 
trichloracetic acid to precipitate cultures, and as a wash along with 
hydrochloric acid. I used hot (95°C) water washes. They filtered the 
M. tuberculosis cultures onto glass fiber filters and counted 
6-emissions from the RNA inside the intact mycobacterial cells, 
creating a heterogeneous liquid scintillation counting system. I did 
not transfer the test cultures nor use filters. I cultured and 
processed the mycobacteria and counted the 6-emissions in the same 
liquid scintillation counting minivials. I solubilized the 
mycobacterial cells to release the RNA so that the tritium could be in 
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intimate contact with the counting cocktail. This produces a 
homogenous counting system. 
Snider's and associates' finding, that McDaniel's and associates' 
3 
and Kunze's and associates' rapid radiometric assays using [ Hjuracil 
provided poor agreement with existing assay procedures, may be the 
result of either the procedures developed or the criterion for 
determining susceptibility rather than the theory of the assay. I 
conducted extensive preliminary experiments to show that incorporation 
3 
of [ H]uracil was a valid measurement of growth and to develop optimum 
conditions for the assay before completion of the development of the 
assay (See Preliminary Investigations to Determine Some Procedures for 
the Rapid Radiometric Assay) because the existing publications seemed 
to show that background information had been neglected. Benitez's and 
3 
associates' assay procedure, using [ Hjuracil, used the techniques 
published by White and associates (3, 47). White and associates had 
used a heterogeneous liquid scintillation counting system by counting 
intact mycobacteria on glass fiber filters. They had made no 
accommodations to make that a more reliable method. Benitez and 
associates also used the criterion published by DeBlanc and associates 
for the evaluation of the CO^ procedure (3, 11). There is no record 
that Benitez and associates investigated thoroughly the criterion 
3 before using it to evaluate the incorporation of [ Hjuracil (3). As a 
result of my preliminary experiments, the procedures I developed used 
more reliable liquid scintillation counting techniques than the other 
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procedures using [^H]uracil incorporation as a measurement of 
susceptibility (3, 24, 31). 
The safe handling of mycobacteria has to be maintained during all 
procedures. Once the initial cultures were established in the 
minivials, they were not removed. In McDaniel's and associates' 
procedure, the cultures were removed, filtered, and washed prior to the 
counting procedure in the Isc. 
There are numerous advantages of a rapid assay system to determine 
the susceptibility of slowly growing mycobacteria to antimicrobials. 
The system I have developed and reported here compares favorably in the 
length of time required for reportable results (3.5 days) to other 
rapid systems (2 to 14 days) (31, 39, 41). The RBA and minivial assay 
provided a technique for rapidly screening a large number of 
antimicrobials to be able to identify potentially useful 
antimicrobials. The minivial assay was simpler to perform than the 
3 
other existing assay techniques using [ H]uracil. The cultures were 
never transferred after they were set up. This minimal handling 
provided for a simpler assay as well as a safer assay. The 
susceptibility of M. paratuberculosisis and M. avium and the MIC of 
antimicrobials can be determined by using the minivial assay. This 
rapid assay deserves further evaluation because of the positive aspects 
of the assay reported in this dissertation. 
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APPENDIX A 
DUBOS BROTH^ 
DEHYDRATED 
Ingredients per liter 
Bacto Casitone 0.5 g 
Bacto Asparagine 2 g 
Tween 80 0.2 g 
Monopotassium. Phosphate 1 g 
Disodium Phosphate (Anhydr.) 2.5 g 
Ferric Ammonium Citrate 50 mg 
Magnesium Sulfate 10 mg 
Calcium Chloride 0.5 mg 
Zinc Sulfate 0.1 mg 
Copper Sulfate 0.1 mg 
METHOD OF PREPARATION 
1. Dissolve 1.3 g in 180 ml distilled or deionized water. 
2. Sterilize in the autoclave for 15 min at 15 lbs pressure 
(121°C). Cool below 50°C. 
3. Aseptically dispense. 
4. Incubate for 24 hours to test sterility. 
^Difco Laboratories, Detroit, MI. 
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APPENDIX B 
MIDDLEBROOK MEDIA 
Ingredients per liter 
Middlebrook 
7H9 Broth 
Middlebrook 
7H10 Agar 
Ammonium Sulfate 
Monopotassium Phosphate 
Disodium Phosphate 
Sodium Citrate 
Magnesium Sulfate 
Calcium Chloride 
Zinc Sulfate 
Copper Sulfate 
L-Glutamic Acid 
Ferric Ammonium Citrate 
Pyridoxine 
Biotin 
Malachite Green 
Bacto Agar 
Solution g/liter (final solution) 
Final pH at 25°C 
0.5 g 
1.0 g 
2.5 g 
0.1 g 
0.05 g 
0.0005 g 
0.001 g 
0.001 g 
0.5 g 
0.04 g 
0.001 g 
0.0005 g 
4.7 g/liter 
6 . 6  +  0 . 2  
0.5 g 
1.5 g 
1.5 g 
0.4 g 
0.025 g 
0.0005 g 
0.001 g 
0.001 g 
0.5 g 
0.04 g 
0.001 g 
0.0005 g 
0.00025 g 
15 g 
19 g/liter 
6 . 6  +  0 . 2  
MIDDLEBROOK ENRICHMENTS 
Ingredients per 100 ml 
(For preparing 1 liter final medium) 
ADC OADC DOAC 
Oleic Acid 
Albumin Fraction V, Bovine 
Dextrose 
Catalase (Beef) 
Sodium Chloride 
Distilled Water 
g 5 
2 g 
0.003 
100 ml 
0.05 g 
5 g 
2 g 
0.004 g 
0.85 g 
100 ml 
0.05 g 
5 g 
0.85 g 
100 ml 
Difco Laboratories, Detroit, MI. 
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METHOD OF PREPARATION 
1. To prepare 1 liter of final medium, suspend the amount of dehy­
drated powder indicated on the package label in 900 ml distilled 
or deionized water containing 0.5 ml Tween 80 and heat to boiling 
to dissolve completely. 
2. Sterilize in the autoclave for 10 or 15 minutes at 15 lbs pressure 
(121°C). Cool to 50 - 55°C. 
3. Aseptically aid 100 ml of the appropriate Middlebrook enrichment 
and mix thoroughly. 
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APPENDIX C 
Egg Yolk Medium 
Peptone 9.0 gm 
NaCl 4.5 gm 
Noble Agar 15.3 gm 
Beef Extract 2.7 gm 
Glycerine 27.0 ml 
Distilled water 870 ml 
4% NaOH to adjust tj pH 7.5 
Ferric mycobactin P ^ 
4.1 ml 
4 ml 
Malachite green (2% solution) 
Eggs 
5.1 ml 
6 
METHOD OF PREPARATION 
Dissolve the first seven ingredients by heating to boiling. Adjust the 
pH to 7.5 with the NaOH. Add the ferric mycobactin P and autoclave in 
an aspirator dispensing bottle for 25 minutes. Cool to 56°C and add 6 
egg yolks. Prepare the eggs as follows: Scrub the eggs with a 
detergent and brush. Rinse eggs with clear water. Let the eggs dry by 
laying them in a sterile towel; then soak them in 75% isopropyl alcohol 
for 30 minutes. Crack the shell at one end with sterile forceps, 
making a 10 mm hole, and remove the egg white with the forceps and 
gravity. Make the hole larger and break the yolk- Twirl the forceps 
to mix the yolk, and pick out the yolk sac; then pour the mixed yolk 
into the dispensing jar of media. Add the sterile solution of 
malachite green. Blend gently with a magnetic^stirrer. Aseptically 
dispense 8 ml of the medium into sterile 25 cm plastic tissue cultures 
flasks. 
Ferric mycobactin is used when isolating and cultivating 
Mycobacterium paratuberculosis. When isolating or cultivating 
Mycobacterium avium, omit ferric mycobactin. To prepare, add 4 ml of 
95% ethanol to a vial containing 2 mg of ferric mycobactin P. After 
the ferric mycobactin is in solution, add to the medium prior to 
autoclaving. 
2 Malachite green solution: Make a 2% solution and autoclave for 
15 min at 121°C. 
3 Eggs must be fresh and from a flock which has not had antibiotics 
in the feed. 
